08 HIV Iinfection Clinical
HIV infection (Clinical)
1. Anonymous Consensus report on HIV and AIDS epidemiology in 2004:
Malaysia, 2004.
2. Anonymous STD prevalence among antenatal mothers in Kuala Lumpur:
Ministry of Health, Malaysia, 2001.
3. Anonymous STD prevalence among sex workers in Kuala Lumpur: Ministry of
Health, Malaysia, 2001.
4. Anonymous HIV/AIDS care and treatment for people who inject drugs in Asia
and the Pacific: an essential practice guide. World Health Organization, 2008.
5. Anonymous Women and HIV in the Asia-Pacific Region. A Development
Practitioner's Guide. Colombo, Sri Lanka: UNDP Regional Centre in Colombo,
2008.
6. Anonymous HIV and Men who have Sex with Men in Asia and the Pacific.
Geneva: UNAIDS, 2006.
7. Anonymous Management of HIV infected persons at primary health care
centres: Ministry of Health, Malaysia, 2002.
8. Anonymous
Guidelines
on
occupational
exposures
to
human
immunodeficiency virus (HIV), Hepatitis B virus (HBV) and Hepatitis C virus,
and recommendations for post exposure prophylaxis (PEP). 2007;.
9. Anonymous Management of HIV infection in pregnant women. 2008;.
10.Aceijas C, Stimson GV, Hickman M, et al. Global overview of injecting drug use
and HIV infection among injecting drug users. AIDS 2004;18(17):2295-2303.
11.Adeeba K. Fighting the HIV
2013;381(9883):2058-2060.
epidemic
in
the
Islamic
world.
Lancet
12.Al-Darraji HA, Kamarulzaman A, Altice FL. Isoniazid preventive therapy in
correctional facilities: a systematic review. Int J Tuberc Lung Dis
2012;16(7):871-879.
13.Arijit G, Shalini C. Opportunistic infection associated to HIV/AIDS in Nepal.
Med J Malaysia 2007;62(1):88
http://www.e-mjm.org/2007/v62n1/HIV_AIDS.pdf
14.Asma I, Johari S, Sim BL, et al. How common is intestinal parasitism in HIVinfected patients in Malaysia? Trop Biomed 2011;28(2):400-410
http://www.msptm.org/files/400_-_410_Asma_I.pdf
15.Asmal HS, Mustafa M, Abdullah S, et al. Pneumocystis pneumonia among HIV
patients in Malaysia. Southeast Asian J Trop Med Public Health
2009;40(6):1293-1297.
Page 1 of 21
16.Azwa I, Khong SY. Human immunodeficiency virus (HIV) in pregnancy: a
review of the guidelines for preventing mother-to-child transmission in
Malaysia. Ann Acad Med Singapore 2012;41(12):587-594.
17.Balkis AK, Zahari CD. HIV prevalence among antenatal mothers in
Terengganu. Malaysian Journal of Public Health Medicine 2003;3(2):48-52
http://www.mjphm.org.my/mjphm/journals/Volume
%203%20(2)%20:%202003/48-52.pdf
18.Barmania S. Malaysia makes progress against HIV, but challenges remain.
Lancet 2013;381(9883):2070-2071
http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613612295.p
df
19.Chawarski MC, Mazlan M, Schottenfeld RS. Heroin dependence and HIV
infection in Malaysia. Drug Alcohol Depend 2006;82 Suppl 1:S39-42.
20.Chawarski MC, Vicknasingam B, Mazlan M, et al. Lifetime ATS use and
increased HIV risk among not-in-treatment opiate injectors in Malaysia. Drug
Alcohol Depend 2012;124(1-2):177-180.
21.Chen PC. An analysis of vulnerability to HIV in Papua New Guinea. Pac Health
Dialog 2001;8(1):166-175.
22. Choi P, Kavasery R, Desai MM, et al. Prevalence and correlates of community
re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD
AIDS 2010;21(6):416-423.
23.Chokephaibulkit K, Kariminia A, Oberdorfer P, et al. Characterizing HIV
Manifestations and Treatment Outcomes of Perinatally Infected Adolescents in
Asia. Pediatr Infect Dis J 2013;.
24.Choon SE, Mathew M, Othman BS. Demographic characteristics and
prevalence of other sexually transmitted diseases in HIV-positive patients
seen in the Dermatology cum Genitourinary Clinic, Hospital Sultanah Aminah,
Johor Bahru. Med J Malaysia 2000;55(2):174-179
http://www.e-mjm.org/2000/v55n2/Demographic_Characteristics.pdf
25.Chou CC, Chronister J, Chou CH, et al. Responsibility attribution of HIV
infection and coping among injection drug users in Malaysia. AIDS Care
2013;25(12):1551-1558.
26.Chow YW, Leong CL, Chow HL, et al. Lactic acidosis in HIV patients receiving
highly active antiretroviral therapy. Med J Malaysia 2007;62(1):78-80
http://www.e-mjm.org/2007/v62n1/highly_active_antiretroviral_therapy.pdf
27.Chuah SY, Leong CK, Pang CW. Dilated common bile duct in opium addicts
with and without biliary symptoms --implication for research in AIDS
cholangiopathy. Singapore Med J 2003;44(5):261-267
http://www.sma.org.sg/smj/4405/4405a5.pdf
Page 2 of 21
28.Copenhaver MM, Tunku N, Ezeabogu I, et al. Adapting an Evidence-Based
Intervention Targeting HIV-Infected Prisoners in Malaysia. AIDS Res Treat
2011;2011:131045.
29.Das Gupta E, Gun SC, Yong Rafidah AR. Early referral of newly diagnosed
rheumatoid arthritis. Family Physician 2003;12(1):16-18.
30.Degenhardt L, Mathers BM, Wirtz AL, et al. What has been achieved in HIV
prevention, treatment and care for people who inject drugs, 2010-2012? A
review of the six highest burden countries. Int J Drug Policy 2013;.
31.Dokubo EK, Kim AA, Le LV, et al. HIV incidence in Asia: a review of available
data and assessment of the epidemic. AIDS Rev 2013;15(2):67-76.
32.Doshi HH. Why should family physicians know about HIV/AIDS. Family
Physician 2003;11(1):9-11.
33.Elliott R. Malaysia: damages awarded after mother infected through
transfusion during pregnancy. Can HIV AIDS Policy Law Rev 2003;8(1):77.
34.Fatan Hamamah Y. Kemunculan penyakit berjangkit dan kesannya terhadap
manusia di Malaysia. Sari 2005;23:153-168
http://eprints.ukm.my/268/1/sari23%5B10%5D.pdf
35.Fauziah MN, Anita S, Shaari N, et al. HIV infection among fishermen in
Terengganu. Malaysian Journal of Public Health Medicine 2002;2(1):21-25
http://www.mjphm.org.my/mjphm/journals/Volume
%202%20(1)%20:%202002/21-25.pdf
36.Fauziah MN, Anita S, Sha'ari BN, et al. HIV-associated risk behaviour among
drug users at drug rehabilitation centres. Med J Malaysia 2003;58(2):268-272
http://www.e-mjm.org/2003/v58n2/HIV_Drug_Users.pdf
37.Foong AL, Ng SF, Lee CK. Identifying HIV/AIDS primary care development
needs. J Adv Nurs 2005;50(2):134-142.
38.Fu JJ, Bazazi AR, Altice FL, et al. Absence of antiretroviral therapy and other
risk factors for morbidity and mortality in Malaysian compulsory drug
detention and rehabilitation centers. PLoS One 2012;7(9):e44249.
39.Ghajarieh AB, Kow KY. Addressing men and gender diversity in education: a
promising solution to the HIV/AIDS epidemic. Health Care Women Int
2011;32(4):314-327.
40.Gill JS, Norzuraida Z. HIV risk behaviours among intravenous drug users.
Malaysian Journal of Psychiatry 2003;11(1):18-23
http://myais.fsktm.um.edu.my/7592/1/HIV_risk_vol11_no1_(18-23)_2003.pdf
Page 3 of 21
41.Gurunathan A. An Epidemiological Evaluation Of TB/HIV - AIDS Status In
Malaysia: Clinical And Microbiological Outcomes Of The Diseases. 2004;.
42.Gurunathan A, Ibrahim P, Syed Sulaiman SA, et al. The Epidemiological Status
Of TB/HIV-AIDS Co-Infected Individuals In Malaysia. Malaysian Journal of
Pharmaceutical Sciences 2004;2(2):38-38
http://myais.fsktm.um.edu.my/6878/1/the_epide_vol2_no2_(38)2004.PDF
43.Haliza MR, Pataki-Schweizer KJ. HIV/AIDS: The Realities, The Challenges. Kuala
Lumpur: Ministry of Health, Malaysia, 2002.
44.Hamid MZ, Aziz NA, Zulkifli ZS, et al. Clinical features and risk factors for HIV
encephalopathy in children. Southeast Asian J Trop Med Public Health
2008;39(2):266-272.
45.Hasan SS, Keong SC, Choong CL, et al. Patient-reported adverse drug
reactions and drug-drug interactions: a cross-sectional study on Malaysian
HIV/AIDS patients. Med Princ Pract 2011;20(3):265-270.
46.Hejazi N, Rajikan R, Kwok Choong LC, et al. Metabolic abnormalities in adult
HIV infected population on antiretroviral medication in Malaysia: a crosssectional survey. BMC Public Health 2013;13(1):758.
47.HIV-CAUSAL Collaboration. Impact of antiretroviral therapy on tuberculosis
incidence among HIV-positive patients in high-income countries. Clin Infect
Dis 2012;54(9):1364-1372.
48.HIV-CAUSAL Collaboration, Cain LE, Logan R, et al. When to initiate combined
antiretroviral therapy to reduce mortality and AIDS-defining illness in HIVinfected persons in developed countries: an observational study. Ann Intern
Med 2011;154(8):509-515.
49.HIV-CAUSAL Collaboration, Ray M, Logan R, et al. The effect of combined
antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS
2010;24(1):123-137.
50.Huang M. HIV among fishers: vulnerability of their partners. In: Anonymous
World Fish Center, 2002.
51.Huang M, Hussein H. The HIV/AIDS epidemic country paper: Malaysia. AIDS
Educ Prev 2004;16(3 Suppl A):100-109.
52.Ismail I, Bulgiba A. Determinants of unsuccessful tuberculosis treatment
outcomes in Malaysian HIV-infected patients. Prev Med 2013;57 Suppl:S27-30.
53.Ismail I, Bulgiba A. Predictors of Death during Tuberculosis Treatment in
TB/HIV Co-Infected Patients in Malaysia. PLoS One 2013;8(8):e73250.
54.Jahanfar S, Lye MS, Rampal L. A randomised controlled trial of peer-adult-led
intervention on improvement of knowledge, attitudes and behaviour of
university students regarding HIV/AIDS in Malaysia. Singapore Med J
2009;50(2):173-180
Page 4 of 21
http://smj.sma.org.sg/5002/5002a9.pdf
55.Jamaiah I, Rohela M, Tok EL, et al. Pneumocystis carinii (jirovecii) pneumonia
(PCP): the most common opportunistic infection observed in HIV/AIDS cases
at the University Malaya Medical Centre, Kuala Lumpur, Malaysia. Southeast
Asian J Trop Med Public Health 2012;43(4):825-831.
56.Jamalluddin AR. Review of pulmonary tuberculosis patients with positive
culture in Kuala Terengganu, 1998-2001. International Medical Journal (IIUM)
2003;2(2)
http://www.e-imj.com/Vol2-No2/Vol2-No2-B13.htm
57.Japaraj RP, Sivalingam N. The prevalence of HIV positive antenatal mothers in
a routine screening programme in two states. Med J Malaysia 2001;56(2):180185
http://www.e-mjm.org/2001/v56n2/HIV_positive_antenatal_mothers.pdf
58.Jing W. A retrospective survey of mucocutaneous manifestations of HIV
infection in Malaysia: analysis of 182 cases. J Dermatol 2000;27(4):225-232.
59.Juita G, Osman A. Drug addiction and HIV infection amongst male in Malaysia,
1994. Jurnal Kesihatan Masyarakat 2006;12(1).
60.Kamal Solhaimi F, Ng CJ. "If you don't try, you wouldn't know right?" Exploring
adolescent sexuality, sexual risk-taking behaviour and HIV risk. Malaysian
Journal of Social Policy and Society 2005;2:146-166.
61.Kamarulzaman A. Impact of HIV prevention programs on drug users in
Malaysia. J Acquir Immune Defic Syndr 2009;52 Suppl 1:S17-9.
62.Kamarulzaman A. Taking stock of two decades of the HIV/AIDS epidemic in
Malaysia. Med J Malaysia 2005;60(1):1-4
http://www.e-mjm.org/2005/v60n1/Hiv_Aids_Epidemic.pdf
63.Khan SA, Moorthy J, Omar H, et al. People living with HIV/AIDS (PLWHA) and
HIV/AIDS associated oral lesions; a study in Malaysia. BMC Public Health
2012;12:850-2458-12-850.
64.Koon Teh Y. HIV-related needs for safety among male-to-female transsexuals
(mak nyah) in Malaysia. SAHARA J 2008;5(4):178-185.
65.Lian YL, Heng BS, Nissapatorn V, et al. AIDS-defining illnesses: a comparison
between before and after commencement of highly active antiretroviral
therapy (HAART). Curr HIV Res 2007;5(5):484-489.
66.Lim YA, Rohela M, Sim BL, et al. Prevalence of cryptosporidiosis in HIV-infected
patients in Kajang Hospital, Selangor. Southeast Asian J Trop Med Public
Health 2005;36 Suppl 4:30-33.
67.Lopez M. A Multi-Step Pace Towards a Cure for HIV: Kick, Kill, and Contain.
AIDS Rev 2013;15(3):190-191.
Page 5 of 21
68.Lubis R, Bulgiba A, Kamarulzaman A, et al. Predictors of death in Malaysian
HIV-infected patients on anti-retroviral therapy. Prev Med 2013;57 Suppl:S546.
69.Manan MM, Ali SM, Khan MA, et al. Review on the demographic and social
impact of methadone-medication therapy on Malaysian patients. Pak J Pharm
Sci 2013;26(4):841-846.
70.Marzuki OA, Fauzi AR, Ayoub S, et al. Prevalence and risk factors of antituberculosis drug-induced hepatitis in Malaysia. Singapore Med J
2008;49(9):688-693
http://smj.sma.org.sg/4909/4909a5.pdf
71.Mazlan M, Schottenfeld RS, Chawarski MC. New challenges and opportunities
in managing substance abuse in Malaysia. Drug Alcohol Rev 2006;25(5):473478.
72.Menon A, Adeeba K. Is it HIV? a handbook for health care providers.
Australasian Society for HIV Medicine, 2009.
73.Mesquita F, Jacka D, Ricard D, et al. Accelerating harm reduction interventions
to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO
(WPRO). Harm Reduct J 2008;5:26-7517-5-26.
74.Mohammad Z, Naing NN. Characteristics of HIV-infected tuberculosis patients
in Kota Bharu Hospital, Kelantan from 1998 to 2001. Southeast Asian J Trop
Med Public Health 2004;35(1):140-143.
75.Mohammad Z, Naing NN, Salleh R, et al. A preliminary study of the influence
of HIV infection in the transmission of tuberculosis. Southeast Asian J Trop
Med Public Health 2002;33(1):92-98.
76.Mohd NM, Yeo J, Huang MS, et al. Nutritional status of children living with HIV
and receiving antiretroviral (ARV) medication in the Klang Valley, Malaysia.
Malays J Nutr 2011;17(1):19-30.
77.Mondal M, Shitan M. Factors affecting the HIV/AIDS epidemic: an ecological
analysis of global data. Afr Health Sci 2013;13(2):301-310.
78.Muhammad Muhsin Z, Bae WH, Nor Zuraida Z, et al. Psychiatric and
substance abuse comorbidity among HIV seropositive and HIV seronegative
prisoners in Malaysia. Am J Drug Alcohol Abuse 2010;36(1):31-38.
79.Naing C, Mak JW, Maung M, et al. Meta-analysis: the association between HIV
infection and extrapulmonary tuberculosis. Lung 2013;191(1):27-34.
80.Nissapatorn V. Lessons learned about opportunistic infections in southeast
Asia. Southeast Asian J Trop Med Public Health 2008;39(4):625-641.
81.Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J
Trop Med Public Health 2009;40(6):1158-1178.
Page 6 of 21
82.Nissapatorn V, Kamarulzaman A, Init I, et al. Seroepidemiology of
toxoplasmosis among HIV-infected patients and healthy blood donors. Med J
Malaysia 2002;57(3):304-310
http://www.e-mjm.org/2002/v57n3/Seroepidemiology.pdf
83.Nissapatorn V, Kuppusamy I, Init I, et al. Pulmonary tuberculosis in HIV/AIDS
Patients. Trop Biomed 2002;19(1):49-53.
84.Nissapatorn V, Kuppusamy I, Sim BL, et al. Tuberculosis in HIV/AIDS patients:
a Malaysian experience. Southeast Asian J Trop Med Public Health
2005;36(4):946-953.
85.Nissapatorn V, Lee CKC, Khairul AA. Impact of pulmonary opportunistic
infections among AIDS patients in General Hospital Kuala Lumpur, Kuala
Lumpur, 2001. Trop Biomed 2001;18(2):117-121.
86.Nissapatorn V, Lee CKC, Khairul AA. The prevalence of AIDS-related skin
diseases in Hospital Kuala Lumpur. Trop Biomed 2002;19(1):55-60.
87.Nissapatorn V, Lee C, Fatt QK, et al. AIDS-related opportunistic infections in
Hospital Kuala Lumpur. Jpn J Infect Dis 2003;56(5-6):187-192.
88.Nissapatorn V, Lee C, Ithoi I, et al. Tuberculosis in AIDS patients. Malays J Med
Sci 2003;10(1):60-64
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557111/pdf/mjms-10-1060.pdf
89.Nissapatorn V, Lee C, Quek KF, et al. Toxoplasmosis in HIV/AIDS patients: a
current situation. Jpn J Infect Dis 2004;57(4):160-165.
90.Nissapatorn V, Lee CK, Cho SM, et al. Toxoplasmosis in HIV/AIDS patients in
Malaysia. Southeast Asian J Trop Med Public Health 2003;34 Suppl 2:80-85.
91.Nissapatorn V, Lee CK, Rohela M, et al. Spectrum of opportunistic infections
among HIV-infected patients in Malaysia. Southeast Asian J Trop Med Public
Health 2004;35 Suppl 2:26-32.
92.Nissapatorn V, Sawangjaroen N. Parasitic infections in HIV infected
individuals: diagnostic & therapeutic challenges. Indian J Med Res
2011;134(6):878-897.
93.Nor Hayati S, Sahlawati M, Suresh Kumar C, et al. A retrospective review on
successful management of Penicillium marneffei infections in patients with
advanced HIV in Hospital Sungai Buloh. Med J Malaysia 2012;67(1):66-70
http://www.e-mjm.org/2012/v67n1/Penicillium_marneffei.pdf
94.Nurfahzura MJ, Hanizasurana H, Zunaina E, et al. Successful treatment of
syphilitic uveitis in HIV-positive patients. Clin Ophthalmol 2013;7:1651-1654.
95.Ong HC, Soo KL. Backcalculation of HIV infection rates in Malaysia. Med J
Malaysia 2006;61(5):616-620
Page 7 of 21
http://www.e-mjm.org/2006/v61n5/HIV_Infection_Malaysia.pdf
96.Poynard T. Management of patients coinfected by HCV and HIV. Med J
Malaysia 2005;60 Suppl B:70-71.
97.Prameela KK. HIV transmission through breastmilk: the science behind the
understanding of current trends and future research. Med J Malaysia
2012;67(6):644-651
http://www.e-mjm.org/2012/v67n6/HIV-transmission-through-breastmilk.pdf
98.Purcell DF, Elliott JH, Ross AL, et al. Towards an HIV Cure: science and debate
from the International AIDS Society 2013 symposium. Retrovirology
2013;10(1):134.
99.Rahman M, Ken W, Norzuriza M, et al. Scenerio of HIV patients reported to
University Kebangsaan Medical Centre during 2006-2009. Bangladesh Journal
of Medical Science 2011;10(1):21-28
http://www.banglajol.info/index.php/BJMS/article/view/7315/5518
100. Razali SM. Drug substitution therapy: a new approach in preventing the
spread of HIV/AIDS in Malaysia. Trop Doct 2008;38(2):109-110.
101. Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the
challenges and responses. Int J Drug Policy 2007;18(2):136-140.
102. Rohani A, Nasir AA. Sexually transmitted infections (including hiv infection)
care management using the "modified syndromic approach" in Malaysia.
Malaysian Journal of Public Health Medicine 2002;2(2):52-57
http://www.mjphm.org.my/mjphm/journals/Volume
%202%20(2)%20:%202002/52-57.pdf
103. Root R. "Mixing" as an ethnoetiology of HIV/AIDS
multinational factories. Med Anthropol Q 2006;20(3):321-344.
in
Malaysia's
104. Root R. "Controlling ourselves, by ourselves": risk assemblages on
Malaysia's assembly lines. Med Anthropol 2008;27(4):405-434.
105. Schottenfeld RS, Chawarski MC, Mahmud M. Maintenance treatment with
buprenorphine and naltrexone for heroin dependence in Malaysia: a
randomised,
double-blind,
placebo-controlled
trial.
Lancet
2008;371(9631):2192-2200.
106. Shetty P. Adeeba Kamarulzaman: fighting HIV/AIDS in Malaysia. Lancet
2013;381(9883):2073-6736(13)61231-3
http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613612313.p
df
107. Siti Norazah Z, Huang MSL, Low WY, Wong YL. Impact of HIV on People
Living with HIV, Their Families and Community in Malaysia. Kuala Lumpur,
Malaysia: United Nations Development Programme, 2007.
Page 8 of 21
108. Suresh N, Balasingam V, Noor Zurani, Md Haris Robson. The transition to
harm reduction: understanding the role of non-governmental organisations in
Malaysia. Int J Drug Policy 2011;22(4):311-317.
109. Syed Wasif G, Syed Azhar SS. Chronic infections and management setting
in drug addicts of MMT program in Pinang, Malaysia. International Journal of
Collaborative Research on Internal Medicine & Public Health 2009;1(2):48-54
http://iomcworld.com/ijcrimph/files/v01-n02-02.pdf
110. Syed IA, Syed Sulaiman SA, Hassali MA, et al. Assessing HIV and AIDS
treatment safety and health-related quality of life among cohort of Malaysian
patients: a discussion on methodological approach. Health Expect 2013;.
111. Tan DB, Yong YK, Tan HY, et al. Immunological profiles of immune
restoration disease presenting as mycobacterial lymphadenitis and
cryptococcal meningitis. HIV Med 2008;9(5):307-316.
112. Tay ST, Rohani MY, Hoo TS, et al. Epidemiology of cryptococcosis in
Malaysia. Mycoses 2010;53(6):509-514.
113. Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance
mutations among antiretroviral-treated HIV-1 patients with suboptimal
virological response in Malaysia. Med Microbiol Immunol 2006;195(2):107112.
114. Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in
Malaysia, 1997-2007. Int J Infect Dis 2009;13(3):307-318.
115. Thana Sehgaran S, Puvaneswaris S, Abdul Razak K, et al. Epidemiology of
HIV/AIDS in Perak Darul Ridzuan. IMR Quarterly Bulletin 2003;(53):19-30
http://ilmusvr.imr.gov.my/bulletin/Bulletin%20Jan%202003.pdf
116. Tung MY, Lee MHG, Ng CG, et al. Identifying depression among the human
immunodeficiency virus (HIV) patients in University Malaya Medical Centre,
Kuala Lumpur, Malaysia. ASEAN Journal of Psychiatry 2009;10(2):135-147
http://www.aseanjournalofpsychiatry.org/pdf/2ASEAN_4_Ng.pdf
117. Velaiutham S, Abdul Razak M, Khatijah B. Characteristics of pulmonary
tuberculosis in HIV seropositive patients in Chest Clinic, Penang Hospital.
Malaysian Journal of Pharmaceutical Sciences 2004;2(2):31-31
http://myais.fsktm.um.edu.my/6863/1/characteristics_vol2_no2_(31)2004.pdf
118. Vicknasingam B, Narayanan S, Navaratnam V. Prevalence rates and risk
factors for hepatitis C among drug users not in treatment in Malaysia. Drug
Alcohol Rev 2009;28(4):447-454.
119. Vicknasingam B, Narayanan S, Navaratnam V. The relative risk of HIV
among IDUs not in treatment in Malaysia. AIDS Care 2009;21(8):984-991.
Page 9 of 21
120. Vickneswari A. An evaluation of the time interval between awareness of
risk and testing and between testing positive and obtaining treatment in a
sample of HIV infected patients in Kuala Lumpur. 2002;.
121. Wan MZ, Syed Hatim N, Naing NN. Characteristics Of HIV-Infected
Tuberculosis Patients In Kota Bharu Hospital, Kelantan From 1998 To 2001.
Malaysian Journal of Pharmaceutical Sciences 2004;2(2):20-20
http://myais.fsktm.um.edu.my/6862/1/character_vol2_no2_(20)2004.pdf
122. Wickersham JA, Zahari MM, Azar MM, et al. Methadone dose at the time of
release from prison significantly influences retention in treatment:
Implications from a pilot study of HIV-infected prisoners transitioning to the
community in Malaysia. Drug Alcohol Depend 2013;132(1-2):378-382.
123. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug
users with HIV infection: a review of barriers and ways forward. Lancet
2010;376(9738):355-366.
124. Wong AR, Rasool AH, Abidin NZ, et al. Sildenafil as treatment for Human
Immunodeficiency Virus-related pulmonary hypertension in a child. J Paediatr
Child Health 2006;42(3):147-148.
125. Wong LP. Prevalence and factors associated with HIV/AIDS-related stigma
and discriminatory attitudes: A cross-sectional nationwide study. Prev Med
2013;57 Suppl:S60-3.
126. Zahariyah Y, Rohani I, Shahrul Bariyah A, et al. A review of HIV antenatal
screening programme in seleted district in Kedah (1999-2002). IMR Quarterly
Bulletin 2003;(55):39-43
http://ilmusvr.imr.gov.my/bulletin/Bulletin%20July%20Oct%202003.pdf
127. Anonymous LISTEN. Young People as a Force for Change in a World with
AIDS. A Collection of Essays on HIV/AIDS by Young Malaysians. Kuala Lumpur,
Malaysia: United Nations Malaysia, 2003.
128. Anonymous 2010 UNGASS Country Progress Report: Malaysia, 2010.
129. Anonymous UNGASS Country Progress Report: Malaysia, 2008.
130. Anonymous Malaysian AIDS Council 2008 Annual Report, 2008.
131. Anonymous Children and AIDS: A stocktaking report. UNICEF, UNAIDS and
WHO, 2007.
132. Anonymous HIV and AIDS and the World of Work in ASEAN. International
Labour Organization, 2005.
133. Anonymous Malaysia 2012. Global AIDS Response. Country Progress
Report. 2012
134. Abu Bakar AM. Bioethics. Malaysian Journal of Pharmacy 2001;1(1):10-15
Page 10 of 21
http://www.cornerstonemsc.net/new_mps/html/publications/journal_of_pharmacy_f.htm.
135. Ahmadi K, Reidpath DD, Allotey P, et al. Professionalisation and social
attitudes: a protocol for measuring changes in HIV/AIDS-related stigma
among healthcare students. BMJ Open 2013;3(5):10.1136/bmjopen-2013002755. Print 2013
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669716/
136. Ahmed SI, Hassali MA, Aziz NA. An assessment of the knowledge,
attitudes, and risk perceptions of pharmacy students regarding HIV/AIDS. Am J
Pharm Educ 2009;73(1):15.
137. Akmal MN, Lee CK, Neng EE, et al. Women's attitudes to HIV screening in
Hospital Muar antenatal clinic. Hospital Muar Medical Journal 2003;1(1):15-19
hmmj2003v1n1_Akmal.pdf.
138. Al-Darraji HA, Razak HA, Ng KP, et al. The Diagnostic Performance of a
Single GeneXpert MTB/RIF Assay in an Intensified Tuberculosis Case Finding
Survey
among
HIV-Infected
Prisoners
in
Malaysia.
PLoS
One
2013;8(9):e73717.
139. Amadora-Nolasco F, Alburo RE, Aguilar EJ, et al. Knowledge and perception
of risk for HIV and condom use among male injecting drug users in Cebu City,
Philippines. Drug Alcohol Rev 2002;21(2):137-143.
140. Anita S, Khatijah MY, Mahamin MY, et al. A cross-sectional study of
knowledge, education, risk behaviour, attitude of HIV/AIDS among factory
workers in three states. Kajian hirisan lintang mengenai pengetahuan, tingkah
laku berisiko dan sikap terhadap HIV/AIDS di kalangan pekerja kilang di tiga
buah negeri.]. Malaysian Journal of Public Health Medicine 2004;4(1):40-46
http://www.mjphm.org.my/mjphm/journals/Volume
%204%20(1)%20:%202004/40-46.pdf
141. Anita S, Zahir WM, Sa'iah A, et al. HIV/AIDS knowledge, attitudes and risk
behaviours among Orang Asli in Peninsular Malaysia. Med J Malaysia
2007;62(3):227-233
http://www.e-mjm.org/2007/v62n3/HIV_AIDS.pdf
142. Azrul MK. Women and Girls. Confronting HIV and AIDS in Malaysia. Ministry
of Health, Malaysia, 2008.
143. Bachireddy C, Bazazi AR, Kavasery R, et al. Attitudes toward opioid
substitution therapy and pre-incarceration HIV transmission behaviors among
HIV-infected prisoners in Malaysia: implications for secondary prevention.
Drug Alcohol Depend 2011;116(1-3):151-157.
144. Bairy KL, Ganaraja B, Indira B, et al. Awareness of post-exposure
prophylaxis guidelines against occupational exposure to HIV in Hospital
Sungai Petani. Med J Malaysia 2005;60(1):10-14
Page 11 of 21
http://www.e-mjm.org/2005/v60n1/Occupational_Exposure_to_HIV.pdf
145. Bruce RD, Govindasamy S, Sylla L, et al. Case series of buprenorphine
injectors in Kuala Lumpur, Malaysia. Am J Drug Alcohol Abuse 2008;34(4):511517.
146. Chai HC, Tay ST. Detection of IgM and IgG antibodies to Cryptococcus
neoformans proteins in blood donors and HIV patients with active
cryptococcosis. Mycoses 2009;52(2):166-170.
147. Chawarski MC, Mazlan M, Schottenfeld RS. Behavioral drug and HIV risk
reduction counseling (BDRC) with abstinence-contingent take-home
buprenorphine: a pilot randomized clinical trial. Drug Alcohol Depend
2008;94(1-3):281-284.
148. Chew BH, Cheong AT. Assessing HIV/AIDS knowledge and stigmatizing
attitudes among medical students in Universiti Putra Malaysia. Med J Malaysia
2013;68(1):24-29
http://www.e-mjm.org/2013/v68n1/knowledge-on-HIV-AIDS.pdf
149. Chew CS, Cherry CL, Kamarulzaman A, et al. A longitudinal study of the
effects of ART on plasma chemokine levels in Malaysian HIV patients. Dis
Markers 2011;31(5):303-309.
150. Chitra P, Bakthavatsalam B, Palvannan T. Beta-2 microglobulin as an
immunological marker to assess the progression of human immunodeficiency
virus infected patients on highly active antiretroviral therapy. Clin Chim Acta
2011;412(11-12):1151-1154.
151. Choi BC. An international comparison of women's health issues in the
Philippines, Thailand, Malaysia, Canada, Hong Kong, and Singapore: the CIDASEAGEP Study. ScientificWorldJournal 2004;4:989-1006.
152. Chow WZ, Ong LY, Razak SH, et al. Molecular diversity of HIV-1 among
people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of
circulating recombinant form (CRF) 33_01B and emergence of multiple unique
recombinant clusters. PLoS One 2013;8(5):e62560.
153. Fong MY, Wong KT, Rohela M, et al. Unusual manifestation of cutaneous
toxoplasmosis in a HIV-positive patient. Trop Biomed 2010;27(3):447-450
http://msptm.org/files/447_-_450_Fong_MY.pdf
154. Gulifeiya A, Rahmah M. Nurses awareness and attitude towards HIV/AIDS
and universal precautions: a cross-sectional study in UKMMC. Jurnal Kesihatan
Masyarakat 2008;14(2):36-45
http://journalarticle.ukm.my/4612/1/Vol14(1)-aniza.pdf
155. Hasan SS, See CK, Choong CL, et al. Reasons, perceived efficacy, and
factors associated with complementary and alternative medicine use among
Malaysian
patients
with
HIV/AIDS.
J
Altern
Complement
Med
2010;16(11):1171-1176.
Page 12 of 21
156. Hasanah CI, Zaliha AR, Mahiran M. Factors influencing the quality of life in
patients with HIV in Malaysia. Qual Life Res 2011;20(1):91-100.
157. Hasnah B, Mohd Hatta M. Knowledge, attitude and practice of prevention
towards HIV/AIDS amongst health personnel in Tapah Hospital , Perak, 1996.
Jurnal Kesihatan Masyarakat 2006;12(1).
158. Hasnah B. Knowledge, attitude and practice of prevention towards
HIV/AIDS amongst health personnel in Tapah Hospital, Perak. 9999;.
159. Ibrahim N, Rampal L, Jamil Z, et al. Effectiveness of peer-led education on
knowledge, attitude and risk behavior practices related to HIV among
students at a Malaysian public university--a randomized controlled trial. Prev
Med 2012;55(5):505-510.
160. Iqbal A, Lim YA, Surin J, et al. High diversity of Cryptosporidium
subgenotypes identified in Malaysian HIV/AIDS individuals targeting gp60
gene. PLoS One 2012;7(2):e31139.
161. Isa WY, Daud KM. Distal renal tubular acidosis in HIV/AIDS patient. Intern
Med 2011;50(16):1765-1768.
162. Jahanfar S, Lim AW, Loh MA, et al. Improvements of knowledge and
perception towards HIV/AIDS among secondary school students after two
hours talk. Med J Malaysia 2008;63(4):288-292
163. Chow WZ, Al-Darraji H, Lee YM, et al. Genome sequences of a novel HIV-1
CRF53_01B identified in Malaysia. J Virol 2012;86(20):11398-11399.
http://www.e-mjm.org/2008/v63n4/HIV_AIDs.pdf
164. Jarmin R, Alwi RI, Shaharuddin S, et al. Common bile duct perforation due
to tuberculosis: a case report. Asian J Surg 2004;27(4):342-344.
165. Jasvindar K. Knowledge of HIV transmission among Malaysians: a
population based study. Journal of Health Management 2012;10(2):10-19
http://www.ihm.moh.gov.my/images/files/PENERBITAN-IPK2012/Journal/Journal-of-Health-Management_01122012_Vol-10-No.2_2012.pdf
166. Jayaram G, Chew MT. Fine needle aspiration cytology of lymph nodes in
HIV-infected individuals. Acta Cytol 2000;44(6):960-966.
167. Kamarulzaman A, Razali K. Malaysia. In: Beyrer C, ed. , 2008:481-500.
168. Kanter J, Koh C, Razali K, et al. Risk behaviour and HIV prevalence among
men who have sex with men in a multiethnic society: a venue-based study in
Kuala Lumpur, Malaysia. Int J STD AIDS 2011;22(1):30-37.
169. Kenali MS, Fadzilah I, Maizaton AA, et al. Concurrent mycobacterial
infection and non-Hodgkin's lymphoma at the same site in an AIDS patient.
Med J Malaysia 2004;59(1):108-111
Page 13 of 21
http://www.e-mjm.org/2004/v59n1/AIDS_Patient.pdf
170. Khairy-Shamel ST, Shatriah I, Adil H, et al. Orbital rhabdomyosarcoma in
an HIV positive child. Orbit 2008;27(5):388-390.
171. Khebir BV, Adam MA, Daud AR, et al. Premarital HIV screening in Johor-(2002-2004). Med J Malaysia 2007;62(1):19-22
http://www.e-mjm.org/2007/v62n1/Premarital_HIV_screening.pdf
172. Khoo SB. Integrating palliative medicine into family medicine. Family
Physician 2003;12(1):19-21.
173. Koh KC, Teh JR, Khan SA. Beliefs and attitudes of medical students from
public and private universities in Malaysia towards individuals with HIV/AIDS.
ScientificWorldJournal 2013;2013:462826
http://downloads.hindawi.com/journals/tswj/2013/462826.pdf
174. Koh KC, Kamarulzaman A. Profiles of men-who-have-sex-with-men seeking
anonymous voluntary HIV counseling and testing at a community-based
centre in Malaysia. Med J Malaysia 2011;66(5):491-494
http://www.e-mjm.org/2011/v66n5/HIV.pdf
175. Koh KC, Lee WY, Eh ZW, et al. Efavirenz does not cause false-positive urine
cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy.
Med J Malaysia 2013;68(3):249-252
http://www.e-mjm.org/2013/v68n3/Efavirenz.pdf
176. Kwa SK. Test your knowledge. What are the chances of contracting HIV
during an unprotected heterosexual encounter? Family Physician
2001;11(3):39-39.
177. Labarga P. Cytomegalovirus, Aging, and HIV: A Perfect Storm. AIDS Rev
2013;15(3):189-190.
178. Kooi ES, Mahayidin M. Pulmonary Tuberculosis in HIV Infection : The
Relationship of the Radiographic Appearance to CD4 T-Lymphocytes Count.
Malays J Med Sci 2001;8(1):34-40
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433962/pdf/mjms-8-1-034.pdf
http://ernd.usm.my/journal/journal/MJMS-8-1-034.pdf
179. Lau KA, Wang B, Kamarulzaman A, et al. Near full-length sequence
analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia.
AIDS Res Hum Retroviruses 2007;23(9):1139-1145.
180. Lau KA, Wang B, Kamarulzaman A, et al. Continuous crossover(s) events of
HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and
extensive HIV-1 evolution in the region. Curr HIV Res 2008;6(2):108-116.
Page 14 of 21
181. Lau KA, Wang B, Miranda-Saksena M, et al. Evidence for possible biological
advantages of the newly emerging HIV-1 circulating recombinant form from
Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and
subtype B. Curr HIV Res 2010;8(3):259-271.
182. Lee CE, Sri Ponnampalavanar S, Syed Omar SF, et al. Evaluation of the
dried blood spot (DBS) collection method as a tool for detection of HIV Ag/Ab,
HBsAg, anti-HBs and anti-HCV in a Malaysian tertiary referral hospital. Ann
Acad Med Singapore 2011;40(10):448-453.
183. Lee CK. Changing approaches in HIV testing. Med J Malaysia 2007;62(1):12
http://www.e-mjm.org/2007/v62n1/HIV_Testing.pdf
184. Lee LK, Chen PC, Lee KK, et al. Premarital sexual intercourse among
adolescents in Malaysia: a cross-sectional Malaysian school survey. Singapore
Med J 2006;47(6):476-481
http://www.sma.org.sg/smj/4706/4706a2.pdf
185. Leng LK, Pancharoen C, Bunupuradah T, et al. Regression of a cervical
spinal mass following highly active antiretroviral therapy (HAART) in child with
advanced human immunodeficiency virus (HIV) disease. J Med Assoc Thai
2007;90(9):1937-1942.
186. Leow YM. By youth, for youth. The Star 2007;.
187. Lim YAL, Asma I, Surin J, et al. First genetic classification of
Cryptosporidium and Giardia from HIV/AIDS patients in Malaysia. Infect Genet
Evol 2011;11(5):968-974
http://ac.els-cdn.com/S1567134811000888/1-s2.0-S1567134811000888main.pdf?_tid=c902cc34-5fad-11e3-b50700000aacb361&acdnat=1386468755_faf9948c01d3a752f3e88a3a78c47ffc
188. Lim A, Tan D, Price P, et al. Proportions of circulating T cells with a
regulatory cell phenotype increase with HIV-associated immune activation
and remain high on antiretroviral therapy. AIDS 2007;21(12):1525-1534.
189. Lim SH, Guadamuz TE, Wei C, et al. Factors associated with unprotected
receptive anal intercourse with internal ejaculation among men who have sex
with men in a large Internet sample from Asia. AIDS Behav 2012;16(7):19791987.
190. Lono A, Kumar S, Chye TT. Detection of microsporidia in local HIV-positive
population in Malaysia. Trans R Soc Trop Med Hyg 2011;105(7):409-413.
191. Low WY, Ng CJ, Kamal Solhaimi F, et al. Sexual issues: let's hear it from the
Malaysian boys. Journal of Men's Health & Gender 2007;4(3):283-291.
192. Lua PL, Norhayati M, Ahmad Kashfi A. HRQoL profile and psychometric
properties assessment of caregiver quality of life instrument among HIV/AIDS
Page 15 of 21
family caregivers
2013;22(1):9-21
in
Terengganu.
Malaysian
Journal
of
Psychiatry
http://mjpsychiatry.org/index.php/mjp/article/viewFile/231/173
193. Lua PL, Norhayati M. Mental health-related experiences and challenges of
informal HIV/AIDS caregivers: a brief review and analysis. ASEAN Journal of
Psychiatry 2012;13(2):197-217
www.aseanjournalofpsychiatry.org/index.php/aseanjournalofpsychiatry/article/
viewFile/111/96
194. Mapanga KG, Mapanga MB. A modern African perspective on the role of
the clinical nurse specialist. Clin Nurse Spec 2008;22(5):226-230.
195. Martin A, Moore C, Mallon PW, et al. Bone mineral density in HIV
participants randomized to raltegravir and lopinavir/ritonavir compared with
standard Second Line therapy. AIDS 2013;.
196. McCormick A, Sultan J. Liver transplantation--patient selection and timing.
Med J Malaysia 2005;60 Suppl B:83-87.
197. Mendelsohn JB, Schilperoord M, Spiegel P, et al. Is Forced Migration a
Barrier to Treatment Success? Similar HIV Treatment Outcomes Among
Refugees and a Surrounding Host Community in Kuala Lumpur, Malaysia. AIDS
Behav 2013;.
198. Mimi Iznita MI. The role of religion in coping with HIV among HIV-positive
patients in Malaysia. 2004;:64-103.
199. Mohamad S, Deris ZZ, Yusoff NK, et al. Assessing subtypes and drug
resistance mutations among HIV-1 infected children who failed antiretroviral
therapy in Kelantan, Malaysia. Braz J Infect Dis 2012;16(3):284-288.
200. Musa MN. Rumah Solehah-Malaysia: Half way home for women and
children with HIV/AIDS. Bangladesh Journal of Medical Science 2009;8(1-2):2932
http://www.banglajol.info/index.php/BJMS/article/view/3187/2682
201. Naing L, Rusli N, Razlan M. The prevalence of, and factors related to,
compliance with glove utilization among nurses in Hospital Universiti Sains
Malaysia. Southeast Asian J Trop Med Public Health 2001;32(3):636-642
http://www.tm.mahidol.ac.th/seameo/2001_32_3/34-2701.pdf
202. Naing CM, Hakim M, Yee DA, et al. HIV/AIDS-related knowledge, attitudes
and perceptions: a cross-sectional household survey. Southeast Asian J Trop
Med Public Health 2010;41(4):952-960.
203. Narwani H, Naing NN. Comparison of socio-economic and demographic
characteristics of HIV and HIV-infected tuberculosis patients in Kota Bharu
Hospital, Kelantan. Jurnal Kesihatan Masyarakat 2004;10:38-40
http://journalarticle.ukm.my/4438/1/2004-02nizam.pdf
Page 16 of 21
204. Nasir MTM, Yeo J, Huang MSL, et al. Nutritional status and the use of
protease inhibitors among Hiv-infected children in Klang Valley, Malaysia.
Malaysian Journal of Medicine and Health Sciences 2011;7(2):73-79
http://medic.upm.edu.my/images/stories/journal/VOL7NO2_JUNE2011.pdf
205. Ng CJ, Kamal SF. Bridging the gap between adolescent sexuality and HIV
risk: the urban Malaysian perspective. Singapore Med J 2006;47(6):482-490
http://www.sma.org.sg/smj/4706/4706a3.pdf
206. Ng KT, Ong LY, Lim SH, et al. Evolutionary history of HIV-1 subtype B and
CRF01_AE transmission clusters among men who have sex with men (MSM) in
Kuala Lumpur, Malaysia. PLoS One 2013;8(6):e67286.
207. Ng KT, Ong LY, Takebe Y, et al. Genome sequence of a novel HIV-1
circulating
recombinant
form
54_01B
from
Malaysia.
J
Virol
2012;86(20):11405-11406.
208. Nimir AR, Osman E, Ibrahim IA, et al. Is it toxoplasma encephalitis, HIV
encephalopathy or brain tuberculoma? BMJ Case Rep 2013;2013:10.1136/bcr2013-008803.
209. Nissapatorn V, Lee CK, Khairul AA. Seroprevalence of toxoplasmosis among
AIDS patients in Hospital Kuala Lumpur, 2001. Singapore Med J
2003;44(4):194-196
http://www.sma.org.sg/smj/4404/4404a4.pdf
210. Niza S, Aishah A, Mohd Aznan MA, et al. Social and HIV/AIDS risk
behaviours in a fishing community. International Journal of Humanities and
Social Science 2011;1(21):251-257
http://www.ijhssnet.com/journals/Vol_1_No_21_Special_Issue_December_2011/
25.pdf
211. Nong S, Liang J. Bone marrow Penicillium marneffei infection in acquired
immunodeficiency syndrome patients: report of 35 cases. Trop Biomed
2013;30(1):89-91.
212. Normala I, Zubaidah J, Nik Shaliza H, et al. Sound HIV knowledge and
common misconceptions about HIV among university students. Malaysian
Journal of Medicine and Health Sciences 2013;9(1):29-34
http://medic.upm.edu.my/images/stories/journal/VOL9NO1_JANUARI2013.pdf
213. Norzila Z. Validity and Reliability of the Malay Translated Medical Outcomes
Study-HIV Health Survey (MOS-HIV) Among HIV Patients. A Multicentre Study.
2007;.
214. Ong LY, Razak SN, Lee YM, et al. Molecular diversity of HIV-1 and
surveillance of transmitted drug resistance variants among treatment Naive
Page 17 of 21
patients, 5 years after active introduction of HAART in Kuala Lumpur,
Malaysia. J Med Virol 2013;.
215. Osteria TS. Adolescent Reproductive Health in Southeast Asia: Malaysia.
Manila: UNESCO, 2008.
216. Othman N, Yip CW, Intan HI, et al. An abdominal mass owing to Penicillium
marneffei in an HIV-infected 7-year-old boy: case report. Ann Trop Paediatr
2006;26(3):259-262.
217. Oyomopito RA, Li PC, Sungkanuparph S, et al. Evaluating immunologic
response and clinical deterioration in treatment-naive patients initiating firstline therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune
Defic Syndr 2013;62(3):293-300.
218. Roshan TM, Rosline H, Ahmed SA, et al. Response rate of Malaysian blood
donors with reactive screening test to transfusion medicine unit calls.
Southeast Asian J Trop Med Public Health 2009;40(6):1315-1321.
219. Rozaidah T. Malaysia. In: Itoh S, ed. Tokyo: Japan Center for International
Exchange, 2006:195-206.
220. Rozina R, Lekhraj R, Lye MS, et al. Knowledge, attitude and practice related
to HIV/AIDS among students in a local university (2007). Malaysian Journal of
Medicine and Health Sciences 2009;5(2):27-41
http://medic.upm.edu.my/images/stories/journal/VOL5NO2_JUNE2009.pdf
221. Saddki N, Noor MM, Norbanee TH, et al. Validity and reliability of the Malay
version of WHOQOL-HIV BREF in patients with HIV infection. AIDS Care
2009;21(10):1271-1278.
222. Sarnon N, Baba I, Jusojf K, et al. Psychosocial reactions of injecting drug
users'(IDU) towards needle syringe exchange program in Malaysia. World
Applied Sciences Journal 2011;12:80-84
http://www.scopus.com/inward/record.url?eid=2-s2.083155166489&partnerID=40&md5=c9c78ebc5869f0d654eee5d052ec16a6
223. Shamilah H, Lokman Hakim.S., Noor Azian MY, et al. Seroprevalence of
Toxoplasma gondii antibodies in HIV positive and negative patients using the
immunofluorescence
antibody
test
(IFAT)
methods.
Trop
Biomed
2001;18(2):137-141.
224. Shankar EM, Vignesh R, Ellegard R, et al. HIV-Mycobacterium tuberculosis
co-infection: A 'danger-couple model' of disease pathogenesis. Pathog Dis
2013;.
225. Sharifa Ezat WP, Mohammad J, Jamsiah M, et al. Knowledge, attitude and
practice about HIV/AIDS and its influencing factors among pregnant mothers
in west of Sabah, Malaysia. Malaysian Journal of Public Health Medicine
2012;12(2):15-23
Page 18 of 21
http://www.mjphm.org.my/mjphm/journals/Volume%2012:2/202-KNOWLEDGE,
%20ATTITUDE%20AND%20PRACTICE%20ABOUT%20HIVAIDS%20AND%20ITS
%20INFLUENCING%20FACTORS%20AMONG%20PREGNANT%20MOTHERS
%20IN%20WEST%20OF%20SABAH,%20MALAYSIA.pdf
226. Silverman JG, Decker MR, McCauley HL, Mack KP. A Regional Assessment of
Sex Trafficking and STI/HIV in Southeast Asia: Connections between Sexual
Exploitation, Violence and Sexual Risk. UNDP Regional Centre in Colombo,
2009.
227. Siti Norazah Z, Wong YL. Knowledge, attitudes and beliefs related to
HIV/AIDS among adolescents in Malaysia. Med J Malaysia 2002;57(1):3-23
http://www.emjm.org/2002/v57n1/Knowledge_Attitudes_beliefs_on_HIV_AIDS.pdf
228. Song A, Richters J, Crawford J, et al. HIV and sexual health knowledge and
sexual experience among Australian-born and overseas-born students in
Sydney. J Adolesc Health 2005;37(3):243
229. Subha ST, Raman R. Nocardia infection of the mastoid
immunocompromised patient. Med J Malaysia 2004;59(5):688-689
in
an
http://www.e-mjm.org/2004/v59n5/Nocardia_Infection.pdf
230. Sujak SL, Abdul-Kadir R, Omar R. Self-disclosure of HIV status: perception
of malaysian HIV-positive subjects towards attitude of dental personnel in
providing oral care. Asia Pac J Public Health 2005;17(1):15-18.
231. Sumatoh HR, Oliver BG, Kumar M, et al. Mycobacterial antibody levels and
immune restoration disease in HIV patients treated in South East Asia.
Biomark Med 2011;5(6):847-853.
232. Sungkanuparph S, Oyomopito R, Sirivichayakul S, et al. HIV-1 drug
resistance mutations among antiretroviral-naive HIV-1-infected patients in
Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring
Study. Clin Infect Dis 2011;52(8):1053-1057.
233. Tan TC, Ong SC, Suresh KG. Genetic variability of Blastocystis sp. isolates
obtained from cancer and HIV/AIDS patients. Parasitol Res 2009;105(5):12831286.
234. Tayib S, van Wijk L, Denny L. Gestational trophoblastic neoplasia and
human immunodeficiency virus infection: a 10-year review. Int J Gynecol
Cancer 2011;21(9):1684-1691.
235. Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of
genotypic drug resistance mutations among antiretroviral-naive HIV type 1
patients in Malaysia. AIDS Res Hum Retroviruses 2006;22(2):121-124.
236. Tee KK, Li XJ, Nohtomi K, et al. Identification of a novel circulating
recombinant form (CRF33_01B) disseminating widely among various risk
populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr
2006;43(5):523-529.
Page 19 of 21
237. Tee KK, Pon CK, Kamarulzaman A, et al. Emergence of HIV-1 CRF01_AE/B
unique recombinant forms in Kuala Lumpur, Malaysia. AIDS 2005;19(2):119126.
238. Tee KK, Saw TL, Pon CK, et al. The evolving molecular epidemiology of HIV
type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum
Retroviruses 2005;21(12):1046-1050.
239. Tee Y, Huang M. Knowledge of HIV/AIDS and attitudes towards people
living with HIV among the general staff of a public university in Malaysia.
SAHARA J 2009;6(4):179-187.
240. Tengku Saifudin TI, Lee C. HIV associated opportunistic pneumonias. Med J
Malaysia 2011;66(1):76-82
http://www.e-mjm.org/2011/v66n1/HIV.pdf
241. Todd CS, Nassiramanesh B, Stanekzai MR, et al. Emerging HIV epidemics in
Muslim countries: assessment of different cultural responses to harm
reduction and implications for HIV control. Curr HIV/AIDS Rep 2007;4(4):151157.
242. TREAT Asia Pediatric HIV Observational Database (TApHOD), International
Epidemiologic Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric
Group. A biregional survey and review of first-line treatment failure and
second-line paediatric antiretroviral access and use in Asia and southern
Africa. J Int AIDS Soc 2011;14:7-2652-14-7.
243. Vinothini A, Khoo EM, Adeeba K. Knowledge of HIV/AIDS among pregnant
women in an urban health clinic - a preliminary study. Family Physician
2005;13(1):10-15.
244. Wong LP. Multi-ethnic perspective of uptake of HIV testing and HIV-related
stigma: A cross-sectional population-based study. AIDS Care 2013;.
245. Wong LP, Chin CK, Low WY, et al. HIV/AIDS-related knowledge among
Malaysian young adults: findings from a nationwide survey. Medscape J Med
2008;10(6):148.
246. Wong LP, Syuhada AR. Stigmatization and discrimination towards people
living with or affected by HIV/AIDS by the general public in Malaysia.
Southeast Asian J Trop Med Public Health 2011;42(5):1119-1129.
247. Zaidah AR, Chan YY, Asma HS, et al. Detection of Cryptosporidium parvum
in HIV-infected patients in Malaysia using a molecular approach. Southeast
Asian J Trop Med Public Health 2008;39(3):511-516.
248. Townsend D. Prisoners with HIV/AIDS: a participatory learning and action
initiative in Malaysia. Trop Doct 2001;31(1):8-10.
249. Wang B, Lau KA, Ong LY, et al. Complex patterns of the HIV-1 epidemic in
Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant
Page 20 of 21
form CRF33_01B and detection of multiple other recombinants. Virology
2007;367(2):288-297.
Page 21 of 21
1. Anonymous Consensus report on HIV and AIDS epidemiology in 2004:
Malaysia, 2004.
2. Anonymous STD prevalence among antenatal mothers in Kuala Lumpur:
Ministry of Health, Malaysia, 2001.
3. Anonymous STD prevalence among sex workers in Kuala Lumpur: Ministry of
Health, Malaysia, 2001.
4. Anonymous HIV/AIDS care and treatment for people who inject drugs in Asia
and the Pacific: an essential practice guide. World Health Organization, 2008.
5. Anonymous Women and HIV in the Asia-Pacific Region. A Development
Practitioner's Guide. Colombo, Sri Lanka: UNDP Regional Centre in Colombo,
2008.
6. Anonymous HIV and Men who have Sex with Men in Asia and the Pacific.
Geneva: UNAIDS, 2006.
7. Anonymous Management of HIV infected persons at primary health care
centres: Ministry of Health, Malaysia, 2002.
8. Anonymous
Guidelines
on
occupational
exposures
to
human
immunodeficiency virus (HIV), Hepatitis B virus (HBV) and Hepatitis C virus,
and recommendations for post exposure prophylaxis (PEP). 2007;.
9. Anonymous Management of HIV infection in pregnant women. 2008;.
10.Aceijas C, Stimson GV, Hickman M, et al. Global overview of injecting drug use
and HIV infection among injecting drug users. AIDS 2004;18(17):2295-2303.
11.Adeeba K. Fighting the HIV
2013;381(9883):2058-2060.
epidemic
in
the
Islamic
world.
Lancet
12.Al-Darraji HA, Kamarulzaman A, Altice FL. Isoniazid preventive therapy in
correctional facilities: a systematic review. Int J Tuberc Lung Dis
2012;16(7):871-879.
13.Arijit G, Shalini C. Opportunistic infection associated to HIV/AIDS in Nepal.
Med J Malaysia 2007;62(1):88
http://www.e-mjm.org/2007/v62n1/HIV_AIDS.pdf
14.Asma I, Johari S, Sim BL, et al. How common is intestinal parasitism in HIVinfected patients in Malaysia? Trop Biomed 2011;28(2):400-410
http://www.msptm.org/files/400_-_410_Asma_I.pdf
15.Asmal HS, Mustafa M, Abdullah S, et al. Pneumocystis pneumonia among HIV
patients in Malaysia. Southeast Asian J Trop Med Public Health
2009;40(6):1293-1297.
Page 1 of 21
16.Azwa I, Khong SY. Human immunodeficiency virus (HIV) in pregnancy: a
review of the guidelines for preventing mother-to-child transmission in
Malaysia. Ann Acad Med Singapore 2012;41(12):587-594.
17.Balkis AK, Zahari CD. HIV prevalence among antenatal mothers in
Terengganu. Malaysian Journal of Public Health Medicine 2003;3(2):48-52
http://www.mjphm.org.my/mjphm/journals/Volume
%203%20(2)%20:%202003/48-52.pdf
18.Barmania S. Malaysia makes progress against HIV, but challenges remain.
Lancet 2013;381(9883):2070-2071
http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613612295.p
df
19.Chawarski MC, Mazlan M, Schottenfeld RS. Heroin dependence and HIV
infection in Malaysia. Drug Alcohol Depend 2006;82 Suppl 1:S39-42.
20.Chawarski MC, Vicknasingam B, Mazlan M, et al. Lifetime ATS use and
increased HIV risk among not-in-treatment opiate injectors in Malaysia. Drug
Alcohol Depend 2012;124(1-2):177-180.
21.Chen PC. An analysis of vulnerability to HIV in Papua New Guinea. Pac Health
Dialog 2001;8(1):166-175.
22. Choi P, Kavasery R, Desai MM, et al. Prevalence and correlates of community
re-entry challenges faced by HIV-infected male prisoners in Malaysia. Int J STD
AIDS 2010;21(6):416-423.
23.Chokephaibulkit K, Kariminia A, Oberdorfer P, et al. Characterizing HIV
Manifestations and Treatment Outcomes of Perinatally Infected Adolescents in
Asia. Pediatr Infect Dis J 2013;.
24.Choon SE, Mathew M, Othman BS. Demographic characteristics and
prevalence of other sexually transmitted diseases in HIV-positive patients
seen in the Dermatology cum Genitourinary Clinic, Hospital Sultanah Aminah,
Johor Bahru. Med J Malaysia 2000;55(2):174-179
http://www.e-mjm.org/2000/v55n2/Demographic_Characteristics.pdf
25.Chou CC, Chronister J, Chou CH, et al. Responsibility attribution of HIV
infection and coping among injection drug users in Malaysia. AIDS Care
2013;25(12):1551-1558.
26.Chow YW, Leong CL, Chow HL, et al. Lactic acidosis in HIV patients receiving
highly active antiretroviral therapy. Med J Malaysia 2007;62(1):78-80
http://www.e-mjm.org/2007/v62n1/highly_active_antiretroviral_therapy.pdf
27.Chuah SY, Leong CK, Pang CW. Dilated common bile duct in opium addicts
with and without biliary symptoms --implication for research in AIDS
cholangiopathy. Singapore Med J 2003;44(5):261-267
http://www.sma.org.sg/smj/4405/4405a5.pdf
Page 2 of 21
28.Copenhaver MM, Tunku N, Ezeabogu I, et al. Adapting an Evidence-Based
Intervention Targeting HIV-Infected Prisoners in Malaysia. AIDS Res Treat
2011;2011:131045.
29.Das Gupta E, Gun SC, Yong Rafidah AR. Early referral of newly diagnosed
rheumatoid arthritis. Family Physician 2003;12(1):16-18.
30.Degenhardt L, Mathers BM, Wirtz AL, et al. What has been achieved in HIV
prevention, treatment and care for people who inject drugs, 2010-2012? A
review of the six highest burden countries. Int J Drug Policy 2013;.
31.Dokubo EK, Kim AA, Le LV, et al. HIV incidence in Asia: a review of available
data and assessment of the epidemic. AIDS Rev 2013;15(2):67-76.
32.Doshi HH. Why should family physicians know about HIV/AIDS. Family
Physician 2003;11(1):9-11.
33.Elliott R. Malaysia: damages awarded after mother infected through
transfusion during pregnancy. Can HIV AIDS Policy Law Rev 2003;8(1):77.
34.Fatan Hamamah Y. Kemunculan penyakit berjangkit dan kesannya terhadap
manusia di Malaysia. Sari 2005;23:153-168
http://eprints.ukm.my/268/1/sari23%5B10%5D.pdf
35.Fauziah MN, Anita S, Shaari N, et al. HIV infection among fishermen in
Terengganu. Malaysian Journal of Public Health Medicine 2002;2(1):21-25
http://www.mjphm.org.my/mjphm/journals/Volume
%202%20(1)%20:%202002/21-25.pdf
36.Fauziah MN, Anita S, Sha'ari BN, et al. HIV-associated risk behaviour among
drug users at drug rehabilitation centres. Med J Malaysia 2003;58(2):268-272
http://www.e-mjm.org/2003/v58n2/HIV_Drug_Users.pdf
37.Foong AL, Ng SF, Lee CK. Identifying HIV/AIDS primary care development
needs. J Adv Nurs 2005;50(2):134-142.
38.Fu JJ, Bazazi AR, Altice FL, et al. Absence of antiretroviral therapy and other
risk factors for morbidity and mortality in Malaysian compulsory drug
detention and rehabilitation centers. PLoS One 2012;7(9):e44249.
39.Ghajarieh AB, Kow KY. Addressing men and gender diversity in education: a
promising solution to the HIV/AIDS epidemic. Health Care Women Int
2011;32(4):314-327.
40.Gill JS, Norzuraida Z. HIV risk behaviours among intravenous drug users.
Malaysian Journal of Psychiatry 2003;11(1):18-23
http://myais.fsktm.um.edu.my/7592/1/HIV_risk_vol11_no1_(18-23)_2003.pdf
Page 3 of 21
41.Gurunathan A. An Epidemiological Evaluation Of TB/HIV - AIDS Status In
Malaysia: Clinical And Microbiological Outcomes Of The Diseases. 2004;.
42.Gurunathan A, Ibrahim P, Syed Sulaiman SA, et al. The Epidemiological Status
Of TB/HIV-AIDS Co-Infected Individuals In Malaysia. Malaysian Journal of
Pharmaceutical Sciences 2004;2(2):38-38
http://myais.fsktm.um.edu.my/6878/1/the_epide_vol2_no2_(38)2004.PDF
43.Haliza MR, Pataki-Schweizer KJ. HIV/AIDS: The Realities, The Challenges. Kuala
Lumpur: Ministry of Health, Malaysia, 2002.
44.Hamid MZ, Aziz NA, Zulkifli ZS, et al. Clinical features and risk factors for HIV
encephalopathy in children. Southeast Asian J Trop Med Public Health
2008;39(2):266-272.
45.Hasan SS, Keong SC, Choong CL, et al. Patient-reported adverse drug
reactions and drug-drug interactions: a cross-sectional study on Malaysian
HIV/AIDS patients. Med Princ Pract 2011;20(3):265-270.
46.Hejazi N, Rajikan R, Kwok Choong LC, et al. Metabolic abnormalities in adult
HIV infected population on antiretroviral medication in Malaysia: a crosssectional survey. BMC Public Health 2013;13(1):758.
47.HIV-CAUSAL Collaboration. Impact of antiretroviral therapy on tuberculosis
incidence among HIV-positive patients in high-income countries. Clin Infect
Dis 2012;54(9):1364-1372.
48.HIV-CAUSAL Collaboration, Cain LE, Logan R, et al. When to initiate combined
antiretroviral therapy to reduce mortality and AIDS-defining illness in HIVinfected persons in developed countries: an observational study. Ann Intern
Med 2011;154(8):509-515.
49.HIV-CAUSAL Collaboration, Ray M, Logan R, et al. The effect of combined
antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS
2010;24(1):123-137.
50.Huang M. HIV among fishers: vulnerability of their partners. In: Anonymous
World Fish Center, 2002.
51.Huang M, Hussein H. The HIV/AIDS epidemic country paper: Malaysia. AIDS
Educ Prev 2004;16(3 Suppl A):100-109.
52.Ismail I, Bulgiba A. Determinants of unsuccessful tuberculosis treatment
outcomes in Malaysian HIV-infected patients. Prev Med 2013;57 Suppl:S27-30.
53.Ismail I, Bulgiba A. Predictors of Death during Tuberculosis Treatment in
TB/HIV Co-Infected Patients in Malaysia. PLoS One 2013;8(8):e73250.
54.Jahanfar S, Lye MS, Rampal L. A randomised controlled trial of peer-adult-led
intervention on improvement of knowledge, attitudes and behaviour of
university students regarding HIV/AIDS in Malaysia. Singapore Med J
2009;50(2):173-180
Page 4 of 21
http://smj.sma.org.sg/5002/5002a9.pdf
55.Jamaiah I, Rohela M, Tok EL, et al. Pneumocystis carinii (jirovecii) pneumonia
(PCP): the most common opportunistic infection observed in HIV/AIDS cases
at the University Malaya Medical Centre, Kuala Lumpur, Malaysia. Southeast
Asian J Trop Med Public Health 2012;43(4):825-831.
56.Jamalluddin AR. Review of pulmonary tuberculosis patients with positive
culture in Kuala Terengganu, 1998-2001. International Medical Journal (IIUM)
2003;2(2)
http://www.e-imj.com/Vol2-No2/Vol2-No2-B13.htm
57.Japaraj RP, Sivalingam N. The prevalence of HIV positive antenatal mothers in
a routine screening programme in two states. Med J Malaysia 2001;56(2):180185
http://www.e-mjm.org/2001/v56n2/HIV_positive_antenatal_mothers.pdf
58.Jing W. A retrospective survey of mucocutaneous manifestations of HIV
infection in Malaysia: analysis of 182 cases. J Dermatol 2000;27(4):225-232.
59.Juita G, Osman A. Drug addiction and HIV infection amongst male in Malaysia,
1994. Jurnal Kesihatan Masyarakat 2006;12(1).
60.Kamal Solhaimi F, Ng CJ. "If you don't try, you wouldn't know right?" Exploring
adolescent sexuality, sexual risk-taking behaviour and HIV risk. Malaysian
Journal of Social Policy and Society 2005;2:146-166.
61.Kamarulzaman A. Impact of HIV prevention programs on drug users in
Malaysia. J Acquir Immune Defic Syndr 2009;52 Suppl 1:S17-9.
62.Kamarulzaman A. Taking stock of two decades of the HIV/AIDS epidemic in
Malaysia. Med J Malaysia 2005;60(1):1-4
http://www.e-mjm.org/2005/v60n1/Hiv_Aids_Epidemic.pdf
63.Khan SA, Moorthy J, Omar H, et al. People living with HIV/AIDS (PLWHA) and
HIV/AIDS associated oral lesions; a study in Malaysia. BMC Public Health
2012;12:850-2458-12-850.
64.Koon Teh Y. HIV-related needs for safety among male-to-female transsexuals
(mak nyah) in Malaysia. SAHARA J 2008;5(4):178-185.
65.Lian YL, Heng BS, Nissapatorn V, et al. AIDS-defining illnesses: a comparison
between before and after commencement of highly active antiretroviral
therapy (HAART). Curr HIV Res 2007;5(5):484-489.
66.Lim YA, Rohela M, Sim BL, et al. Prevalence of cryptosporidiosis in HIV-infected
patients in Kajang Hospital, Selangor. Southeast Asian J Trop Med Public
Health 2005;36 Suppl 4:30-33.
67.Lopez M. A Multi-Step Pace Towards a Cure for HIV: Kick, Kill, and Contain.
AIDS Rev 2013;15(3):190-191.
Page 5 of 21
68.Lubis R, Bulgiba A, Kamarulzaman A, et al. Predictors of death in Malaysian
HIV-infected patients on anti-retroviral therapy. Prev Med 2013;57 Suppl:S546.
69.Manan MM, Ali SM, Khan MA, et al. Review on the demographic and social
impact of methadone-medication therapy on Malaysian patients. Pak J Pharm
Sci 2013;26(4):841-846.
70.Marzuki OA, Fauzi AR, Ayoub S, et al. Prevalence and risk factors of antituberculosis drug-induced hepatitis in Malaysia. Singapore Med J
2008;49(9):688-693
http://smj.sma.org.sg/4909/4909a5.pdf
71.Mazlan M, Schottenfeld RS, Chawarski MC. New challenges and opportunities
in managing substance abuse in Malaysia. Drug Alcohol Rev 2006;25(5):473478.
72.Menon A, Adeeba K. Is it HIV? a handbook for health care providers.
Australasian Society for HIV Medicine, 2009.
73.Mesquita F, Jacka D, Ricard D, et al. Accelerating harm reduction interventions
to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO
(WPRO). Harm Reduct J 2008;5:26-7517-5-26.
74.Mohammad Z, Naing NN. Characteristics of HIV-infected tuberculosis patients
in Kota Bharu Hospital, Kelantan from 1998 to 2001. Southeast Asian J Trop
Med Public Health 2004;35(1):140-143.
75.Mohammad Z, Naing NN, Salleh R, et al. A preliminary study of the influence
of HIV infection in the transmission of tuberculosis. Southeast Asian J Trop
Med Public Health 2002;33(1):92-98.
76.Mohd NM, Yeo J, Huang MS, et al. Nutritional status of children living with HIV
and receiving antiretroviral (ARV) medication in the Klang Valley, Malaysia.
Malays J Nutr 2011;17(1):19-30.
77.Mondal M, Shitan M. Factors affecting the HIV/AIDS epidemic: an ecological
analysis of global data. Afr Health Sci 2013;13(2):301-310.
78.Muhammad Muhsin Z, Bae WH, Nor Zuraida Z, et al. Psychiatric and
substance abuse comorbidity among HIV seropositive and HIV seronegative
prisoners in Malaysia. Am J Drug Alcohol Abuse 2010;36(1):31-38.
79.Naing C, Mak JW, Maung M, et al. Meta-analysis: the association between HIV
infection and extrapulmonary tuberculosis. Lung 2013;191(1):27-34.
80.Nissapatorn V. Lessons learned about opportunistic infections in southeast
Asia. Southeast Asian J Trop Med Public Health 2008;39(4):625-641.
81.Nissapatorn V. Toxoplasmosis in HIV/AIDS: a living legacy. Southeast Asian J
Trop Med Public Health 2009;40(6):1158-1178.
Page 6 of 21
82.Nissapatorn V, Kamarulzaman A, Init I, et al. Seroepidemiology of
toxoplasmosis among HIV-infected patients and healthy blood donors. Med J
Malaysia 2002;57(3):304-310
http://www.e-mjm.org/2002/v57n3/Seroepidemiology.pdf
83.Nissapatorn V, Kuppusamy I, Init I, et al. Pulmonary tuberculosis in HIV/AIDS
Patients. Trop Biomed 2002;19(1):49-53.
84.Nissapatorn V, Kuppusamy I, Sim BL, et al. Tuberculosis in HIV/AIDS patients:
a Malaysian experience. Southeast Asian J Trop Med Public Health
2005;36(4):946-953.
85.Nissapatorn V, Lee CKC, Khairul AA. Impact of pulmonary opportunistic
infections among AIDS patients in General Hospital Kuala Lumpur, Kuala
Lumpur, 2001. Trop Biomed 2001;18(2):117-121.
86.Nissapatorn V, Lee CKC, Khairul AA. The prevalence of AIDS-related skin
diseases in Hospital Kuala Lumpur. Trop Biomed 2002;19(1):55-60.
87.Nissapatorn V, Lee C, Fatt QK, et al. AIDS-related opportunistic infections in
Hospital Kuala Lumpur. Jpn J Infect Dis 2003;56(5-6):187-192.
88.Nissapatorn V, Lee C, Ithoi I, et al. Tuberculosis in AIDS patients. Malays J Med
Sci 2003;10(1):60-64
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557111/pdf/mjms-10-1060.pdf
89.Nissapatorn V, Lee C, Quek KF, et al. Toxoplasmosis in HIV/AIDS patients: a
current situation. Jpn J Infect Dis 2004;57(4):160-165.
90.Nissapatorn V, Lee CK, Cho SM, et al. Toxoplasmosis in HIV/AIDS patients in
Malaysia. Southeast Asian J Trop Med Public Health 2003;34 Suppl 2:80-85.
91.Nissapatorn V, Lee CK, Rohela M, et al. Spectrum of opportunistic infections
among HIV-infected patients in Malaysia. Southeast Asian J Trop Med Public
Health 2004;35 Suppl 2:26-32.
92.Nissapatorn V, Sawangjaroen N. Parasitic infections in HIV infected
individuals: diagnostic & therapeutic challenges. Indian J Med Res
2011;134(6):878-897.
93.Nor Hayati S, Sahlawati M, Suresh Kumar C, et al. A retrospective review on
successful management of Penicillium marneffei infections in patients with
advanced HIV in Hospital Sungai Buloh. Med J Malaysia 2012;67(1):66-70
http://www.e-mjm.org/2012/v67n1/Penicillium_marneffei.pdf
94.Nurfahzura MJ, Hanizasurana H, Zunaina E, et al. Successful treatment of
syphilitic uveitis in HIV-positive patients. Clin Ophthalmol 2013;7:1651-1654.
95.Ong HC, Soo KL. Backcalculation of HIV infection rates in Malaysia. Med J
Malaysia 2006;61(5):616-620
Page 7 of 21
http://www.e-mjm.org/2006/v61n5/HIV_Infection_Malaysia.pdf
96.Poynard T. Management of patients coinfected by HCV and HIV. Med J
Malaysia 2005;60 Suppl B:70-71.
97.Prameela KK. HIV transmission through breastmilk: the science behind the
understanding of current trends and future research. Med J Malaysia
2012;67(6):644-651
http://www.e-mjm.org/2012/v67n6/HIV-transmission-through-breastmilk.pdf
98.Purcell DF, Elliott JH, Ross AL, et al. Towards an HIV Cure: science and debate
from the International AIDS Society 2013 symposium. Retrovirology
2013;10(1):134.
99.Rahman M, Ken W, Norzuriza M, et al. Scenerio of HIV patients reported to
University Kebangsaan Medical Centre during 2006-2009. Bangladesh Journal
of Medical Science 2011;10(1):21-28
http://www.banglajol.info/index.php/BJMS/article/view/7315/5518
100. Razali SM. Drug substitution therapy: a new approach in preventing the
spread of HIV/AIDS in Malaysia. Trop Doct 2008;38(2):109-110.
101. Reid G, Kamarulzaman A, Sran SK. Malaysia and harm reduction: the
challenges and responses. Int J Drug Policy 2007;18(2):136-140.
102. Rohani A, Nasir AA. Sexually transmitted infections (including hiv infection)
care management using the "modified syndromic approach" in Malaysia.
Malaysian Journal of Public Health Medicine 2002;2(2):52-57
http://www.mjphm.org.my/mjphm/journals/Volume
%202%20(2)%20:%202002/52-57.pdf
103. Root R. "Mixing" as an ethnoetiology of HIV/AIDS
multinational factories. Med Anthropol Q 2006;20(3):321-344.
in
Malaysia's
104. Root R. "Controlling ourselves, by ourselves": risk assemblages on
Malaysia's assembly lines. Med Anthropol 2008;27(4):405-434.
105. Schottenfeld RS, Chawarski MC, Mahmud M. Maintenance treatment with
buprenorphine and naltrexone for heroin dependence in Malaysia: a
randomised,
double-blind,
placebo-controlled
trial.
Lancet
2008;371(9631):2192-2200.
106. Shetty P. Adeeba Kamarulzaman: fighting HIV/AIDS in Malaysia. Lancet
2013;381(9883):2073-6736(13)61231-3
http://download.thelancet.com/pdfs/journals/lancet/PIIS0140673613612313.p
df
107. Siti Norazah Z, Huang MSL, Low WY, Wong YL. Impact of HIV on People
Living with HIV, Their Families and Community in Malaysia. Kuala Lumpur,
Malaysia: United Nations Development Programme, 2007.
Page 8 of 21
108. Suresh N, Balasingam V, Noor Zurani, Md Haris Robson. The transition to
harm reduction: understanding the role of non-governmental organisations in
Malaysia. Int J Drug Policy 2011;22(4):311-317.
109. Syed Wasif G, Syed Azhar SS. Chronic infections and management setting
in drug addicts of MMT program in Pinang, Malaysia. International Journal of
Collaborative Research on Internal Medicine & Public Health 2009;1(2):48-54
http://iomcworld.com/ijcrimph/files/v01-n02-02.pdf
110. Syed IA, Syed Sulaiman SA, Hassali MA, et al. Assessing HIV and AIDS
treatment safety and health-related quality of life among cohort of Malaysian
patients: a discussion on methodological approach. Health Expect 2013;.
111. Tan DB, Yong YK, Tan HY, et al. Immunological profiles of immune
restoration disease presenting as mycobacterial lymphadenitis and
cryptococcal meningitis. HIV Med 2008;9(5):307-316.
112. Tay ST, Rohani MY, Hoo TS, et al. Epidemiology of cryptococcosis in
Malaysia. Mycoses 2010;53(6):509-514.
113. Tee KK, Kamarulzaman A, Ng KP. Prevalence and pattern of drug resistance
mutations among antiretroviral-treated HIV-1 patients with suboptimal
virological response in Malaysia. Med Microbiol Immunol 2006;195(2):107112.
114. Tee KK, Takebe Y, Kamarulzaman A. Emerging and re-emerging viruses in
Malaysia, 1997-2007. Int J Infect Dis 2009;13(3):307-318.
115. Thana Sehgaran S, Puvaneswaris S, Abdul Razak K, et al. Epidemiology of
HIV/AIDS in Perak Darul Ridzuan. IMR Quarterly Bulletin 2003;(53):19-30
http://ilmusvr.imr.gov.my/bulletin/Bulletin%20Jan%202003.pdf
116. Tung MY, Lee MHG, Ng CG, et al. Identifying depression among the human
immunodeficiency virus (HIV) patients in University Malaya Medical Centre,
Kuala Lumpur, Malaysia. ASEAN Journal of Psychiatry 2009;10(2):135-147
http://www.aseanjournalofpsychiatry.org/pdf/2ASEAN_4_Ng.pdf
117. Velaiutham S, Abdul Razak M, Khatijah B. Characteristics of pulmonary
tuberculosis in HIV seropositive patients in Chest Clinic, Penang Hospital.
Malaysian Journal of Pharmaceutical Sciences 2004;2(2):31-31
http://myais.fsktm.um.edu.my/6863/1/characteristics_vol2_no2_(31)2004.pdf
118. Vicknasingam B, Narayanan S, Navaratnam V. Prevalence rates and risk
factors for hepatitis C among drug users not in treatment in Malaysia. Drug
Alcohol Rev 2009;28(4):447-454.
119. Vicknasingam B, Narayanan S, Navaratnam V. The relative risk of HIV
among IDUs not in treatment in Malaysia. AIDS Care 2009;21(8):984-991.
Page 9 of 21
120. Vickneswari A. An evaluation of the time interval between awareness of
risk and testing and between testing positive and obtaining treatment in a
sample of HIV infected patients in Kuala Lumpur. 2002;.
121. Wan MZ, Syed Hatim N, Naing NN. Characteristics Of HIV-Infected
Tuberculosis Patients In Kota Bharu Hospital, Kelantan From 1998 To 2001.
Malaysian Journal of Pharmaceutical Sciences 2004;2(2):20-20
http://myais.fsktm.um.edu.my/6862/1/character_vol2_no2_(20)2004.pdf
122. Wickersham JA, Zahari MM, Azar MM, et al. Methadone dose at the time of
release from prison significantly influences retention in treatment:
Implications from a pilot study of HIV-infected prisoners transitioning to the
community in Malaysia. Drug Alcohol Depend 2013;132(1-2):378-382.
123. Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug
users with HIV infection: a review of barriers and ways forward. Lancet
2010;376(9738):355-366.
124. Wong AR, Rasool AH, Abidin NZ, et al. Sildenafil as treatment for Human
Immunodeficiency Virus-related pulmonary hypertension in a child. J Paediatr
Child Health 2006;42(3):147-148.
125. Wong LP. Prevalence and factors associated with HIV/AIDS-related stigma
and discriminatory attitudes: A cross-sectional nationwide study. Prev Med
2013;57 Suppl:S60-3.
126. Zahariyah Y, Rohani I, Shahrul Bariyah A, et al. A review of HIV antenatal
screening programme in seleted district in Kedah (1999-2002). IMR Quarterly
Bulletin 2003;(55):39-43
http://ilmusvr.imr.gov.my/bulletin/Bulletin%20July%20Oct%202003.pdf
127. Anonymous LISTEN. Young People as a Force for Change in a World with
AIDS. A Collection of Essays on HIV/AIDS by Young Malaysians. Kuala Lumpur,
Malaysia: United Nations Malaysia, 2003.
128. Anonymous 2010 UNGASS Country Progress Report: Malaysia, 2010.
129. Anonymous UNGASS Country Progress Report: Malaysia, 2008.
130. Anonymous Malaysian AIDS Council 2008 Annual Report, 2008.
131. Anonymous Children and AIDS: A stocktaking report. UNICEF, UNAIDS and
WHO, 2007.
132. Anonymous HIV and AIDS and the World of Work in ASEAN. International
Labour Organization, 2005.
133. Anonymous Malaysia 2012. Global AIDS Response. Country Progress
Report. 2012
134. Abu Bakar AM. Bioethics. Malaysian Journal of Pharmacy 2001;1(1):10-15
Page 10 of 21
http://www.cornerstonemsc.net/new_mps/html/publications/journal_of_pharmacy_f.htm.
135. Ahmadi K, Reidpath DD, Allotey P, et al. Professionalisation and social
attitudes: a protocol for measuring changes in HIV/AIDS-related stigma
among healthcare students. BMJ Open 2013;3(5):10.1136/bmjopen-2013002755. Print 2013
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669716/
136. Ahmed SI, Hassali MA, Aziz NA. An assessment of the knowledge,
attitudes, and risk perceptions of pharmacy students regarding HIV/AIDS. Am J
Pharm Educ 2009;73(1):15.
137. Akmal MN, Lee CK, Neng EE, et al. Women's attitudes to HIV screening in
Hospital Muar antenatal clinic. Hospital Muar Medical Journal 2003;1(1):15-19
hmmj2003v1n1_Akmal.pdf.
138. Al-Darraji HA, Razak HA, Ng KP, et al. The Diagnostic Performance of a
Single GeneXpert MTB/RIF Assay in an Intensified Tuberculosis Case Finding
Survey
among
HIV-Infected
Prisoners
in
Malaysia.
PLoS
One
2013;8(9):e73717.
139. Amadora-Nolasco F, Alburo RE, Aguilar EJ, et al. Knowledge and perception
of risk for HIV and condom use among male injecting drug users in Cebu City,
Philippines. Drug Alcohol Rev 2002;21(2):137-143.
140. Anita S, Khatijah MY, Mahamin MY, et al. A cross-sectional study of
knowledge, education, risk behaviour, attitude of HIV/AIDS among factory
workers in three states. Kajian hirisan lintang mengenai pengetahuan, tingkah
laku berisiko dan sikap terhadap HIV/AIDS di kalangan pekerja kilang di tiga
buah negeri.]. Malaysian Journal of Public Health Medicine 2004;4(1):40-46
http://www.mjphm.org.my/mjphm/journals/Volume
%204%20(1)%20:%202004/40-46.pdf
141. Anita S, Zahir WM, Sa'iah A, et al. HIV/AIDS knowledge, attitudes and risk
behaviours among Orang Asli in Peninsular Malaysia. Med J Malaysia
2007;62(3):227-233
http://www.e-mjm.org/2007/v62n3/HIV_AIDS.pdf
142. Azrul MK. Women and Girls. Confronting HIV and AIDS in Malaysia. Ministry
of Health, Malaysia, 2008.
143. Bachireddy C, Bazazi AR, Kavasery R, et al. Attitudes toward opioid
substitution therapy and pre-incarceration HIV transmission behaviors among
HIV-infected prisoners in Malaysia: implications for secondary prevention.
Drug Alcohol Depend 2011;116(1-3):151-157.
144. Bairy KL, Ganaraja B, Indira B, et al. Awareness of post-exposure
prophylaxis guidelines against occupational exposure to HIV in Hospital
Sungai Petani. Med J Malaysia 2005;60(1):10-14
Page 11 of 21
http://www.e-mjm.org/2005/v60n1/Occupational_Exposure_to_HIV.pdf
145. Bruce RD, Govindasamy S, Sylla L, et al. Case series of buprenorphine
injectors in Kuala Lumpur, Malaysia. Am J Drug Alcohol Abuse 2008;34(4):511517.
146. Chai HC, Tay ST. Detection of IgM and IgG antibodies to Cryptococcus
neoformans proteins in blood donors and HIV patients with active
cryptococcosis. Mycoses 2009;52(2):166-170.
147. Chawarski MC, Mazlan M, Schottenfeld RS. Behavioral drug and HIV risk
reduction counseling (BDRC) with abstinence-contingent take-home
buprenorphine: a pilot randomized clinical trial. Drug Alcohol Depend
2008;94(1-3):281-284.
148. Chew BH, Cheong AT. Assessing HIV/AIDS knowledge and stigmatizing
attitudes among medical students in Universiti Putra Malaysia. Med J Malaysia
2013;68(1):24-29
http://www.e-mjm.org/2013/v68n1/knowledge-on-HIV-AIDS.pdf
149. Chew CS, Cherry CL, Kamarulzaman A, et al. A longitudinal study of the
effects of ART on plasma chemokine levels in Malaysian HIV patients. Dis
Markers 2011;31(5):303-309.
150. Chitra P, Bakthavatsalam B, Palvannan T. Beta-2 microglobulin as an
immunological marker to assess the progression of human immunodeficiency
virus infected patients on highly active antiretroviral therapy. Clin Chim Acta
2011;412(11-12):1151-1154.
151. Choi BC. An international comparison of women's health issues in the
Philippines, Thailand, Malaysia, Canada, Hong Kong, and Singapore: the CIDASEAGEP Study. ScientificWorldJournal 2004;4:989-1006.
152. Chow WZ, Ong LY, Razak SH, et al. Molecular diversity of HIV-1 among
people who inject drugs in Kuala Lumpur, Malaysia: massive expansion of
circulating recombinant form (CRF) 33_01B and emergence of multiple unique
recombinant clusters. PLoS One 2013;8(5):e62560.
153. Fong MY, Wong KT, Rohela M, et al. Unusual manifestation of cutaneous
toxoplasmosis in a HIV-positive patient. Trop Biomed 2010;27(3):447-450
http://msptm.org/files/447_-_450_Fong_MY.pdf
154. Gulifeiya A, Rahmah M. Nurses awareness and attitude towards HIV/AIDS
and universal precautions: a cross-sectional study in UKMMC. Jurnal Kesihatan
Masyarakat 2008;14(2):36-45
http://journalarticle.ukm.my/4612/1/Vol14(1)-aniza.pdf
155. Hasan SS, See CK, Choong CL, et al. Reasons, perceived efficacy, and
factors associated with complementary and alternative medicine use among
Malaysian
patients
with
HIV/AIDS.
J
Altern
Complement
Med
2010;16(11):1171-1176.
Page 12 of 21
156. Hasanah CI, Zaliha AR, Mahiran M. Factors influencing the quality of life in
patients with HIV in Malaysia. Qual Life Res 2011;20(1):91-100.
157. Hasnah B, Mohd Hatta M. Knowledge, attitude and practice of prevention
towards HIV/AIDS amongst health personnel in Tapah Hospital , Perak, 1996.
Jurnal Kesihatan Masyarakat 2006;12(1).
158. Hasnah B. Knowledge, attitude and practice of prevention towards
HIV/AIDS amongst health personnel in Tapah Hospital, Perak. 9999;.
159. Ibrahim N, Rampal L, Jamil Z, et al. Effectiveness of peer-led education on
knowledge, attitude and risk behavior practices related to HIV among
students at a Malaysian public university--a randomized controlled trial. Prev
Med 2012;55(5):505-510.
160. Iqbal A, Lim YA, Surin J, et al. High diversity of Cryptosporidium
subgenotypes identified in Malaysian HIV/AIDS individuals targeting gp60
gene. PLoS One 2012;7(2):e31139.
161. Isa WY, Daud KM. Distal renal tubular acidosis in HIV/AIDS patient. Intern
Med 2011;50(16):1765-1768.
162. Jahanfar S, Lim AW, Loh MA, et al. Improvements of knowledge and
perception towards HIV/AIDS among secondary school students after two
hours talk. Med J Malaysia 2008;63(4):288-292
163. Chow WZ, Al-Darraji H, Lee YM, et al. Genome sequences of a novel HIV-1
CRF53_01B identified in Malaysia. J Virol 2012;86(20):11398-11399.
http://www.e-mjm.org/2008/v63n4/HIV_AIDs.pdf
164. Jarmin R, Alwi RI, Shaharuddin S, et al. Common bile duct perforation due
to tuberculosis: a case report. Asian J Surg 2004;27(4):342-344.
165. Jasvindar K. Knowledge of HIV transmission among Malaysians: a
population based study. Journal of Health Management 2012;10(2):10-19
http://www.ihm.moh.gov.my/images/files/PENERBITAN-IPK2012/Journal/Journal-of-Health-Management_01122012_Vol-10-No.2_2012.pdf
166. Jayaram G, Chew MT. Fine needle aspiration cytology of lymph nodes in
HIV-infected individuals. Acta Cytol 2000;44(6):960-966.
167. Kamarulzaman A, Razali K. Malaysia. In: Beyrer C, ed. , 2008:481-500.
168. Kanter J, Koh C, Razali K, et al. Risk behaviour and HIV prevalence among
men who have sex with men in a multiethnic society: a venue-based study in
Kuala Lumpur, Malaysia. Int J STD AIDS 2011;22(1):30-37.
169. Kenali MS, Fadzilah I, Maizaton AA, et al. Concurrent mycobacterial
infection and non-Hodgkin's lymphoma at the same site in an AIDS patient.
Med J Malaysia 2004;59(1):108-111
Page 13 of 21
http://www.e-mjm.org/2004/v59n1/AIDS_Patient.pdf
170. Khairy-Shamel ST, Shatriah I, Adil H, et al. Orbital rhabdomyosarcoma in
an HIV positive child. Orbit 2008;27(5):388-390.
171. Khebir BV, Adam MA, Daud AR, et al. Premarital HIV screening in Johor-(2002-2004). Med J Malaysia 2007;62(1):19-22
http://www.e-mjm.org/2007/v62n1/Premarital_HIV_screening.pdf
172. Khoo SB. Integrating palliative medicine into family medicine. Family
Physician 2003;12(1):19-21.
173. Koh KC, Teh JR, Khan SA. Beliefs and attitudes of medical students from
public and private universities in Malaysia towards individuals with HIV/AIDS.
ScientificWorldJournal 2013;2013:462826
http://downloads.hindawi.com/journals/tswj/2013/462826.pdf
174. Koh KC, Kamarulzaman A. Profiles of men-who-have-sex-with-men seeking
anonymous voluntary HIV counseling and testing at a community-based
centre in Malaysia. Med J Malaysia 2011;66(5):491-494
http://www.e-mjm.org/2011/v66n5/HIV.pdf
175. Koh KC, Lee WY, Eh ZW, et al. Efavirenz does not cause false-positive urine
cannabis test in HIV-infected patients on Highly Active Anti-Retroviral Therapy.
Med J Malaysia 2013;68(3):249-252
http://www.e-mjm.org/2013/v68n3/Efavirenz.pdf
176. Kwa SK. Test your knowledge. What are the chances of contracting HIV
during an unprotected heterosexual encounter? Family Physician
2001;11(3):39-39.
177. Labarga P. Cytomegalovirus, Aging, and HIV: A Perfect Storm. AIDS Rev
2013;15(3):189-190.
178. Kooi ES, Mahayidin M. Pulmonary Tuberculosis in HIV Infection : The
Relationship of the Radiographic Appearance to CD4 T-Lymphocytes Count.
Malays J Med Sci 2001;8(1):34-40
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433962/pdf/mjms-8-1-034.pdf
http://ernd.usm.my/journal/journal/MJMS-8-1-034.pdf
179. Lau KA, Wang B, Kamarulzaman A, et al. Near full-length sequence
analysis of a Unique CRF01_AE/B recombinant from Kuala Lumpur, Malaysia.
AIDS Res Hum Retroviruses 2007;23(9):1139-1145.
180. Lau KA, Wang B, Kamarulzaman A, et al. Continuous crossover(s) events of
HIV-1 CRF01_AE and B subtype strains in Malaysia: evidence of rapid and
extensive HIV-1 evolution in the region. Curr HIV Res 2008;6(2):108-116.
Page 14 of 21
181. Lau KA, Wang B, Miranda-Saksena M, et al. Evidence for possible biological
advantages of the newly emerging HIV-1 circulating recombinant form from
Malaysia - CRF33_01B in comparison to its progenitors - CRF01_AE and
subtype B. Curr HIV Res 2010;8(3):259-271.
182. Lee CE, Sri Ponnampalavanar S, Syed Omar SF, et al. Evaluation of the
dried blood spot (DBS) collection method as a tool for detection of HIV Ag/Ab,
HBsAg, anti-HBs and anti-HCV in a Malaysian tertiary referral hospital. Ann
Acad Med Singapore 2011;40(10):448-453.
183. Lee CK. Changing approaches in HIV testing. Med J Malaysia 2007;62(1):12
http://www.e-mjm.org/2007/v62n1/HIV_Testing.pdf
184. Lee LK, Chen PC, Lee KK, et al. Premarital sexual intercourse among
adolescents in Malaysia: a cross-sectional Malaysian school survey. Singapore
Med J 2006;47(6):476-481
http://www.sma.org.sg/smj/4706/4706a2.pdf
185. Leng LK, Pancharoen C, Bunupuradah T, et al. Regression of a cervical
spinal mass following highly active antiretroviral therapy (HAART) in child with
advanced human immunodeficiency virus (HIV) disease. J Med Assoc Thai
2007;90(9):1937-1942.
186. Leow YM. By youth, for youth. The Star 2007;.
187. Lim YAL, Asma I, Surin J, et al. First genetic classification of
Cryptosporidium and Giardia from HIV/AIDS patients in Malaysia. Infect Genet
Evol 2011;11(5):968-974
http://ac.els-cdn.com/S1567134811000888/1-s2.0-S1567134811000888main.pdf?_tid=c902cc34-5fad-11e3-b50700000aacb361&acdnat=1386468755_faf9948c01d3a752f3e88a3a78c47ffc
188. Lim A, Tan D, Price P, et al. Proportions of circulating T cells with a
regulatory cell phenotype increase with HIV-associated immune activation
and remain high on antiretroviral therapy. AIDS 2007;21(12):1525-1534.
189. Lim SH, Guadamuz TE, Wei C, et al. Factors associated with unprotected
receptive anal intercourse with internal ejaculation among men who have sex
with men in a large Internet sample from Asia. AIDS Behav 2012;16(7):19791987.
190. Lono A, Kumar S, Chye TT. Detection of microsporidia in local HIV-positive
population in Malaysia. Trans R Soc Trop Med Hyg 2011;105(7):409-413.
191. Low WY, Ng CJ, Kamal Solhaimi F, et al. Sexual issues: let's hear it from the
Malaysian boys. Journal of Men's Health & Gender 2007;4(3):283-291.
192. Lua PL, Norhayati M, Ahmad Kashfi A. HRQoL profile and psychometric
properties assessment of caregiver quality of life instrument among HIV/AIDS
Page 15 of 21
family caregivers
2013;22(1):9-21
in
Terengganu.
Malaysian
Journal
of
Psychiatry
http://mjpsychiatry.org/index.php/mjp/article/viewFile/231/173
193. Lua PL, Norhayati M. Mental health-related experiences and challenges of
informal HIV/AIDS caregivers: a brief review and analysis. ASEAN Journal of
Psychiatry 2012;13(2):197-217
www.aseanjournalofpsychiatry.org/index.php/aseanjournalofpsychiatry/article/
viewFile/111/96
194. Mapanga KG, Mapanga MB. A modern African perspective on the role of
the clinical nurse specialist. Clin Nurse Spec 2008;22(5):226-230.
195. Martin A, Moore C, Mallon PW, et al. Bone mineral density in HIV
participants randomized to raltegravir and lopinavir/ritonavir compared with
standard Second Line therapy. AIDS 2013;.
196. McCormick A, Sultan J. Liver transplantation--patient selection and timing.
Med J Malaysia 2005;60 Suppl B:83-87.
197. Mendelsohn JB, Schilperoord M, Spiegel P, et al. Is Forced Migration a
Barrier to Treatment Success? Similar HIV Treatment Outcomes Among
Refugees and a Surrounding Host Community in Kuala Lumpur, Malaysia. AIDS
Behav 2013;.
198. Mimi Iznita MI. The role of religion in coping with HIV among HIV-positive
patients in Malaysia. 2004;:64-103.
199. Mohamad S, Deris ZZ, Yusoff NK, et al. Assessing subtypes and drug
resistance mutations among HIV-1 infected children who failed antiretroviral
therapy in Kelantan, Malaysia. Braz J Infect Dis 2012;16(3):284-288.
200. Musa MN. Rumah Solehah-Malaysia: Half way home for women and
children with HIV/AIDS. Bangladesh Journal of Medical Science 2009;8(1-2):2932
http://www.banglajol.info/index.php/BJMS/article/view/3187/2682
201. Naing L, Rusli N, Razlan M. The prevalence of, and factors related to,
compliance with glove utilization among nurses in Hospital Universiti Sains
Malaysia. Southeast Asian J Trop Med Public Health 2001;32(3):636-642
http://www.tm.mahidol.ac.th/seameo/2001_32_3/34-2701.pdf
202. Naing CM, Hakim M, Yee DA, et al. HIV/AIDS-related knowledge, attitudes
and perceptions: a cross-sectional household survey. Southeast Asian J Trop
Med Public Health 2010;41(4):952-960.
203. Narwani H, Naing NN. Comparison of socio-economic and demographic
characteristics of HIV and HIV-infected tuberculosis patients in Kota Bharu
Hospital, Kelantan. Jurnal Kesihatan Masyarakat 2004;10:38-40
http://journalarticle.ukm.my/4438/1/2004-02nizam.pdf
Page 16 of 21
204. Nasir MTM, Yeo J, Huang MSL, et al. Nutritional status and the use of
protease inhibitors among Hiv-infected children in Klang Valley, Malaysia.
Malaysian Journal of Medicine and Health Sciences 2011;7(2):73-79
http://medic.upm.edu.my/images/stories/journal/VOL7NO2_JUNE2011.pdf
205. Ng CJ, Kamal SF. Bridging the gap between adolescent sexuality and HIV
risk: the urban Malaysian perspective. Singapore Med J 2006;47(6):482-490
http://www.sma.org.sg/smj/4706/4706a3.pdf
206. Ng KT, Ong LY, Lim SH, et al. Evolutionary history of HIV-1 subtype B and
CRF01_AE transmission clusters among men who have sex with men (MSM) in
Kuala Lumpur, Malaysia. PLoS One 2013;8(6):e67286.
207. Ng KT, Ong LY, Takebe Y, et al. Genome sequence of a novel HIV-1
circulating
recombinant
form
54_01B
from
Malaysia.
J
Virol
2012;86(20):11405-11406.
208. Nimir AR, Osman E, Ibrahim IA, et al. Is it toxoplasma encephalitis, HIV
encephalopathy or brain tuberculoma? BMJ Case Rep 2013;2013:10.1136/bcr2013-008803.
209. Nissapatorn V, Lee CK, Khairul AA. Seroprevalence of toxoplasmosis among
AIDS patients in Hospital Kuala Lumpur, 2001. Singapore Med J
2003;44(4):194-196
http://www.sma.org.sg/smj/4404/4404a4.pdf
210. Niza S, Aishah A, Mohd Aznan MA, et al. Social and HIV/AIDS risk
behaviours in a fishing community. International Journal of Humanities and
Social Science 2011;1(21):251-257
http://www.ijhssnet.com/journals/Vol_1_No_21_Special_Issue_December_2011/
25.pdf
211. Nong S, Liang J. Bone marrow Penicillium marneffei infection in acquired
immunodeficiency syndrome patients: report of 35 cases. Trop Biomed
2013;30(1):89-91.
212. Normala I, Zubaidah J, Nik Shaliza H, et al. Sound HIV knowledge and
common misconceptions about HIV among university students. Malaysian
Journal of Medicine and Health Sciences 2013;9(1):29-34
http://medic.upm.edu.my/images/stories/journal/VOL9NO1_JANUARI2013.pdf
213. Norzila Z. Validity and Reliability of the Malay Translated Medical Outcomes
Study-HIV Health Survey (MOS-HIV) Among HIV Patients. A Multicentre Study.
2007;.
214. Ong LY, Razak SN, Lee YM, et al. Molecular diversity of HIV-1 and
surveillance of transmitted drug resistance variants among treatment Naive
Page 17 of 21
patients, 5 years after active introduction of HAART in Kuala Lumpur,
Malaysia. J Med Virol 2013;.
215. Osteria TS. Adolescent Reproductive Health in Southeast Asia: Malaysia.
Manila: UNESCO, 2008.
216. Othman N, Yip CW, Intan HI, et al. An abdominal mass owing to Penicillium
marneffei in an HIV-infected 7-year-old boy: case report. Ann Trop Paediatr
2006;26(3):259-262.
217. Oyomopito RA, Li PC, Sungkanuparph S, et al. Evaluating immunologic
response and clinical deterioration in treatment-naive patients initiating firstline therapies infected with HIV-1 CRF01_AE and subtype B. J Acquir Immune
Defic Syndr 2013;62(3):293-300.
218. Roshan TM, Rosline H, Ahmed SA, et al. Response rate of Malaysian blood
donors with reactive screening test to transfusion medicine unit calls.
Southeast Asian J Trop Med Public Health 2009;40(6):1315-1321.
219. Rozaidah T. Malaysia. In: Itoh S, ed. Tokyo: Japan Center for International
Exchange, 2006:195-206.
220. Rozina R, Lekhraj R, Lye MS, et al. Knowledge, attitude and practice related
to HIV/AIDS among students in a local university (2007). Malaysian Journal of
Medicine and Health Sciences 2009;5(2):27-41
http://medic.upm.edu.my/images/stories/journal/VOL5NO2_JUNE2009.pdf
221. Saddki N, Noor MM, Norbanee TH, et al. Validity and reliability of the Malay
version of WHOQOL-HIV BREF in patients with HIV infection. AIDS Care
2009;21(10):1271-1278.
222. Sarnon N, Baba I, Jusojf K, et al. Psychosocial reactions of injecting drug
users'(IDU) towards needle syringe exchange program in Malaysia. World
Applied Sciences Journal 2011;12:80-84
http://www.scopus.com/inward/record.url?eid=2-s2.083155166489&partnerID=40&md5=c9c78ebc5869f0d654eee5d052ec16a6
223. Shamilah H, Lokman Hakim.S., Noor Azian MY, et al. Seroprevalence of
Toxoplasma gondii antibodies in HIV positive and negative patients using the
immunofluorescence
antibody
test
(IFAT)
methods.
Trop
Biomed
2001;18(2):137-141.
224. Shankar EM, Vignesh R, Ellegard R, et al. HIV-Mycobacterium tuberculosis
co-infection: A 'danger-couple model' of disease pathogenesis. Pathog Dis
2013;.
225. Sharifa Ezat WP, Mohammad J, Jamsiah M, et al. Knowledge, attitude and
practice about HIV/AIDS and its influencing factors among pregnant mothers
in west of Sabah, Malaysia. Malaysian Journal of Public Health Medicine
2012;12(2):15-23
Page 18 of 21
http://www.mjphm.org.my/mjphm/journals/Volume%2012:2/202-KNOWLEDGE,
%20ATTITUDE%20AND%20PRACTICE%20ABOUT%20HIVAIDS%20AND%20ITS
%20INFLUENCING%20FACTORS%20AMONG%20PREGNANT%20MOTHERS
%20IN%20WEST%20OF%20SABAH,%20MALAYSIA.pdf
226. Silverman JG, Decker MR, McCauley HL, Mack KP. A Regional Assessment of
Sex Trafficking and STI/HIV in Southeast Asia: Connections between Sexual
Exploitation, Violence and Sexual Risk. UNDP Regional Centre in Colombo,
2009.
227. Siti Norazah Z, Wong YL. Knowledge, attitudes and beliefs related to
HIV/AIDS among adolescents in Malaysia. Med J Malaysia 2002;57(1):3-23
http://www.emjm.org/2002/v57n1/Knowledge_Attitudes_beliefs_on_HIV_AIDS.pdf
228. Song A, Richters J, Crawford J, et al. HIV and sexual health knowledge and
sexual experience among Australian-born and overseas-born students in
Sydney. J Adolesc Health 2005;37(3):243
229. Subha ST, Raman R. Nocardia infection of the mastoid
immunocompromised patient. Med J Malaysia 2004;59(5):688-689
in
an
http://www.e-mjm.org/2004/v59n5/Nocardia_Infection.pdf
230. Sujak SL, Abdul-Kadir R, Omar R. Self-disclosure of HIV status: perception
of malaysian HIV-positive subjects towards attitude of dental personnel in
providing oral care. Asia Pac J Public Health 2005;17(1):15-18.
231. Sumatoh HR, Oliver BG, Kumar M, et al. Mycobacterial antibody levels and
immune restoration disease in HIV patients treated in South East Asia.
Biomark Med 2011;5(6):847-853.
232. Sungkanuparph S, Oyomopito R, Sirivichayakul S, et al. HIV-1 drug
resistance mutations among antiretroviral-naive HIV-1-infected patients in
Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring
Study. Clin Infect Dis 2011;52(8):1053-1057.
233. Tan TC, Ong SC, Suresh KG. Genetic variability of Blastocystis sp. isolates
obtained from cancer and HIV/AIDS patients. Parasitol Res 2009;105(5):12831286.
234. Tayib S, van Wijk L, Denny L. Gestational trophoblastic neoplasia and
human immunodeficiency virus infection: a 10-year review. Int J Gynecol
Cancer 2011;21(9):1684-1691.
235. Tee KK, Kamarulzaman A, Ng KP. Short communication: low prevalence of
genotypic drug resistance mutations among antiretroviral-naive HIV type 1
patients in Malaysia. AIDS Res Hum Retroviruses 2006;22(2):121-124.
236. Tee KK, Li XJ, Nohtomi K, et al. Identification of a novel circulating
recombinant form (CRF33_01B) disseminating widely among various risk
populations in Kuala Lumpur, Malaysia. J Acquir Immune Defic Syndr
2006;43(5):523-529.
Page 19 of 21
237. Tee KK, Pon CK, Kamarulzaman A, et al. Emergence of HIV-1 CRF01_AE/B
unique recombinant forms in Kuala Lumpur, Malaysia. AIDS 2005;19(2):119126.
238. Tee KK, Saw TL, Pon CK, et al. The evolving molecular epidemiology of HIV
type 1 among injecting drug users (IDUs) in Malaysia. AIDS Res Hum
Retroviruses 2005;21(12):1046-1050.
239. Tee Y, Huang M. Knowledge of HIV/AIDS and attitudes towards people
living with HIV among the general staff of a public university in Malaysia.
SAHARA J 2009;6(4):179-187.
240. Tengku Saifudin TI, Lee C. HIV associated opportunistic pneumonias. Med J
Malaysia 2011;66(1):76-82
http://www.e-mjm.org/2011/v66n1/HIV.pdf
241. Todd CS, Nassiramanesh B, Stanekzai MR, et al. Emerging HIV epidemics in
Muslim countries: assessment of different cultural responses to harm
reduction and implications for HIV control. Curr HIV/AIDS Rep 2007;4(4):151157.
242. TREAT Asia Pediatric HIV Observational Database (TApHOD), International
Epidemiologic Databases to Evaluate AIDS (IeDEA) Southern Africa Paediatric
Group. A biregional survey and review of first-line treatment failure and
second-line paediatric antiretroviral access and use in Asia and southern
Africa. J Int AIDS Soc 2011;14:7-2652-14-7.
243. Vinothini A, Khoo EM, Adeeba K. Knowledge of HIV/AIDS among pregnant
women in an urban health clinic - a preliminary study. Family Physician
2005;13(1):10-15.
244. Wong LP. Multi-ethnic perspective of uptake of HIV testing and HIV-related
stigma: A cross-sectional population-based study. AIDS Care 2013;.
245. Wong LP, Chin CK, Low WY, et al. HIV/AIDS-related knowledge among
Malaysian young adults: findings from a nationwide survey. Medscape J Med
2008;10(6):148.
246. Wong LP, Syuhada AR. Stigmatization and discrimination towards people
living with or affected by HIV/AIDS by the general public in Malaysia.
Southeast Asian J Trop Med Public Health 2011;42(5):1119-1129.
247. Zaidah AR, Chan YY, Asma HS, et al. Detection of Cryptosporidium parvum
in HIV-infected patients in Malaysia using a molecular approach. Southeast
Asian J Trop Med Public Health 2008;39(3):511-516.
248. Townsend D. Prisoners with HIV/AIDS: a participatory learning and action
initiative in Malaysia. Trop Doct 2001;31(1):8-10.
249. Wang B, Lau KA, Ong LY, et al. Complex patterns of the HIV-1 epidemic in
Kuala Lumpur, Malaysia: evidence for expansion of circulating recombinant
Page 20 of 21
form CRF33_01B and detection of multiple other recombinants. Virology
2007;367(2):288-297.
Page 21 of 21